FARO TECHNOLOGIES INC - Annual Report: 2004 (Form 10-K)
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
10-K
(Mark
One)
x |
Annual
report pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934 For the fiscal year ended December 31, 2004
or |
o |
Transition
report pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934 |
For the
transition period from ________ to _________
Commission
File Number 0-23081
FARO
TECHNOLOGIES, INC.
(Exact
name of Registrant as specified in its charter)
Florida |
59-3157093 |
(State
or other jurisdiction of
incorporation or organization) |
(I.R.S.
Employer Identification No.) |
125
Technology Park, Lake Mary, FL |
32746 |
(Address
of Principal Executive Offices) |
(Zip
Code) |
(Registrant's
Telephone Number, Including Area Code): (407) 333-9911
Securities
to be registered pursuant to Section 12(b) of the Act:
Title
of Each Class |
Name
of Each Exchange On
Which Registered |
None |
None |
Securities
to be registered pursuant to Section 12(g) of the Act: Common Stock, par value
$.001
Indicate
by check mark whether the registrant: (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. Yes
[X] No [
]
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K is not contained herein, and will not be contained, to the best
of registrant's knowledge, in definite proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]
Indicate
by check mark whether the registrant is an accelerated filer (as defined in
Exchange Act Rule 12b-2). Yes
[X] No [
]
As of
March 9, 2005, there were outstanding 14,051,707 shares of common stock. The
aggregate market value of the voting stock held by non-affiliates of the
Registrant as of March 9, 2005 was $343 million based on the last sale on such
date on the Nasdaq National Market.
DOCUMENTS
INCORPORATED BY REFERENCE
The
Registrant has incorporated by reference into part II of this Form 10-K portions
of its proxy statement for its Annual Meeting of Shareholders currently
scheduled to be held May 17, 2005.
PART
I
CAUTIONARY
STATEMENTS FOR FORWARD-LOOKING INFORMATION
FARO
Technologies, Inc. (the Company) has made "forward-looking statements" in this
report (within the meaning of the Private Securities Litigation Reform Act of
1995). Statements that are not historical facts or that describe our plans,
beliefs, goals, intentions, objectives, projections, expectations, assumptions,
strategies, or future
events
are forward-looking statements. In addition, words such as "may," "will,"
"believe," "plan," "should," "could," "seek," "expect," "anticipate," "intend,"
"estimate," "goal," "objective," “project,” “forecast,” “target,” “goal” and
similar words, or discussions of our strategy or other intentions identify
forward-looking statements. Other written or oral statements that constitute
forward-looking statements, also may be made by the Company from time to
time.
Forward-looking
statements are not guarantees of future performance and are subject to a number
of known and unknown risks, uncertainties, and other factors that could cause
actual results to differ materially from those expressed or implied by such
forward-looking statements. Consequently, undue reliance should not be placed on
these forward-looking statements. We do not intend to update any forward-looking
statements, whether as a result of new information, future events, or otherwise,
unless otherwise required by law. Important factors that could cause a material
difference in the actual results from those contemplated in such forward-looking
statements include among others those under "Cautionary Statements" and
elsewhere in this report and the following:
· |
our
inability to further penetrate our customer base;
|
· |
development
by others of new or improved products, processes or technologies that make
our products obsolete or less competitive; |
· |
our
inability to maintain our technological advantage by developing new
products and enhancing our existing
products; |
· |
our
inability to successfully identify and acquire target companies or achieve
expected benefits from acquisitions that are consummated;
|
· |
the
cyclical nature of the industries of our customers and the financial
condition of our customers; |
· |
the
fact that the market potential for the CAM2 market and the potential
adoption rate for our products are difficult to quantify and
predict; |
· |
the
inability to protect our patents and other proprietary rights in the
United States and foreign countries and the assertion of infringement
claims against us; |
· |
fluctuations
in our annual and quarterly operating results as a result of a number of
factors; |
· |
the
inability of our products to displace traditional measurement devices and
attain broad market acceptance; |
· |
the
impact of competitive products and pricing in the CAM2 market and the
broader market for measurement and inspection devices;
|
· |
the
effects of increased competition as a result of recent consolidation in
the CAM2 market; |
· |
risks
associated with expanding international operations, such as fluctuations
in currency exchange rates, difficulties in staffing and managing foreign
operations, political and economic instability, and the burdens of
complying with a wide variety of foreign laws and labor
practices; |
· |
our
inability to continue to grow sales in the Asia Pacific
region; |
· |
our
inability to keep our financial results within our target goals as a
result of various potential factors such as investments in potential
acquisitions or strategic sales, product or other
initiatives; |
· |
our
inability to find less expensive alternatives to stock options to attract
and retain employees; |
· |
the
loss of our Chief Executive Officer, our President and Chief Operating
Officer, our Executive Vice President, Secretary and Treasurer, or our
Chief Financial Officer or other key personnel;
|
· |
the
failure to effectively manage our growth; |
· |
difficulty
in predicting our effective tax rate; |
· |
the
loss of a key supplier and the inability to find a sufficient alternative
supplier in a reasonable period or on commercially reasonable terms;
and |
· |
the
matters set forth under “Cautionary Statements” in “Management’s
Discussion and Analysis of Financial Condition and Results of Operations”
below. |
2
Item
1.
Business.
The
Company designs, develops, markets and supports portable, software-driven, 3-D
measurement systems that are used in a broad range of manufacturing and
industrial applications. The Company's principal products are the Faro Arm, Faro
Scan Arm and Faro Gage articulated measuring devices, the Faro Laser Tracker,
and their companion CAM2 software, which provide for Computer-Aided
Design (CAD)-based
inspection and/or factory-level statistical process control. Together, these
products integrate the measurement and quality inspection function with CAD
software to improve productivity, enhance product quality and decrease rework
and scrap in the manufacturing process. The Company uses the acronym “CAM2” for
this process, which stands for computer-aided manufacturing measurement. The
Company's products bring precision measurement, quality inspection and
specification conformance capabilities, integrated with leading CAD software, to
the factory floor. The Company is a pioneer in the development, marketing and
manufacturing of 3-D measurement technology in manufacturing and industrial
applications. The Company's products have been purchased by approximately 3,800
customers worldwide, ranging from small machine shops to such large
manufacturing and industrial companies as Audi, Bell Helicopter, Boeing, British
Aerospace, Caterpillar, Daimler Chrysler, General Electric, General Motors,
Honda, Johnson Controls, Komatsu Dresser, Lockheed Martin, Nissan, Siemens,
Volkswagen among many others.
We were
founded in 1982 and we re-incorporated in Florida in 1992. Our worldwide
headquarters are located at 125 Technology Park, Lake Mary, Florida 32746, and
our telephone number is (407) 333-9911.
Industry
Background
The
Company believes that there are three principal forces driving the need for its
products and services: 1) the widespread use by manufacturers of CAD in product
development which shortens product cycles; 2) the adoption by manufacturers of
quality standards such as Six Sigma and ISO-9000 (and its offshoot QS-9000),
which stress the measurement of every step in a manufacturing process to reduce
or eliminate defects, and 3) the inability of traditional measurement devices to
address many manufacturing problems, especially those related to large
components for products such as automobiles, aircraft, and heavy duty
construction equipment.
CAD
changes the manufacturing process. The
creation of physical products involves the processes of design, engineering,
production and measurement and quality inspection. These basic processes have
been profoundly affected by the computer hardware and software revolution that
began in the 1980s. CAD software was developed to automate the design process,
providing manufacturers with computerized 3-D design capability. Today, most
manufacturers use some form of CAD software to create designs and engineering
specifications for new products and to quantify and modify designs and
specifications for existing products. The use of CAD can shorten the time
between design changes. While
manufacturers previously designed their products to be in production for longer
periods of time, current manufacturing practices must accommodate more frequent
product introductions and modifications, while satisfying more stringent quality
and safety standards. Assembly
fixtures and measurement tools must be figuratively linked to the CAD design to
enable production to keep up with the rate of design change.
3
Quality
standards dictate measurement to reduce defects. QS-9000
is the name given to the Quality System Requirements of the automotive industry
that were developed by Chrysler, Ford, General Motors and major truck
manufacturers and issued in late 1994. Companies that become registered under
QS-9000 are considered to have higher standards and better quality products. Six
Sigma embodies the principles of total quality management that focus on
measuring results and reducing product or service failure rates to 3.4 per
million. All aspects of a Six Sigma company's infrastructure must be analyzed,
and if necessary, restructured to increase revenues and raise customer
satisfaction levels. The all-encompassing nature of these and other quality
standards has resulted in manufacturers measuring every aspect of their process,
including stages of product assembly that may have never been measured before,
in part because of the lack of suitable measurement equipment.
Traditional
products don’t measure up. A
significant aspect of the manufacturing process, which traditionally has not
benefited from computer-aided technology, is measurement and quality inspection.
Historically, manufacturers have measured and inspected products using
hand-measurement tools such as scales, calipers, micrometers and plumb lines for
simple measuring tasks, test (or check) fixtures for certain large manufactured
products and traditional coordinate measurement machines (CMM) for objects that
require higher precision measurement. However, the broader utility of each of
these measurement methods is limited.
Although
hand-measurement tools are often appropriate for simple geometric measurements,
including hole diameters or length and width of a rectangular component, their
use for complex part measurements, such as the fender of a car, is limited. Also
these devices do not allow for the measurements to be directly compared to the
CAD model of the part. Test fixtures (customized fixed tools used to make
comparative measurements of complex production parts to “master parts”) are
relatively expensive and must be reworked or discarded each time a dimensional
change is made in the part being measured. In addition, these manual measuring
devices do not permit the manufacturer to compare the dimensions of an object
with its CAD model.
Conventional
CMMs are generally large, fixed-base machines that provide very high levels of
precision and provide a link to the CAD model of the object being measured.
However, fixed-base CMMs require the object being measured be brought to the CMM
and the object fit within the CMMs measurement grid. As manufactured
subassemblies increase in size and become integrated into even larger
assemblies, they become less transportable, thus diminishing the utility of a
conventional CMM. Consequently, manufacturers must continue to use
hand-measuring tools, or expensive customized test fixtures, in order to measure
large or unconventionally shaped objects. Some parts or assemblies are not
easily accessible and cannot be measured at all using traditional
devices.
Escalating
global competition has created a demand for higher quality products with shorter
life cycles. Manufacturers require more rapid design, greater control of the
manufacturing process, tools to compare components to their CAD specifications
and the ability to precisely measure components that cannot be measured or
inspected by conventional devices. Moreover, they increasingly require
measurement capabilities to be integrated into the manufacturing process and to
be available on the factory floor.
FARO
Products
The
Faro Arm.
The Faro
Arm is a combination of a portable, six or seven-axis, instrumented articulated
measurement arm, a touch screen computer, and software programs under the
acronym CAM2.
q |
Articulated
Arm -
Each articulated arm is comprised of three major joints, each of which may
consist of one, two or three axes of motion. The articulated arm is
available in a variety of sizes, configurations and precision levels that
are suitable for a broad range of applications. To take a measurement, the
operator simply touches the object to be measured with a probe at the end
of the arm and presses a button. Data can be captured at either individual
points or a series of points. Digital rotational transducers located at
each of the joints of the arm measure the angles at those joints. This
rotational measurement data is transmitted to an on-board controller that
converts the arm angles to precise locations in 3-D space using “xyz”
position coordinates and “ijk” orientation
coordinates. |
4
q |
Touch
Screen Computer -
One of the main goals of the Faro Arm system is to provide computer-based
inspection without requiring the operator to program the inspection
software or even have to touch a keyboard. As such the Company-developed
software (see the following section) runs entirely by the operator
touching simple icons on the touch screen, not unlike how a restaurant
waiter enters an order. The computers are not manufactured by the Company,
but are purchased from various suppliers. |
q |
CAM2
Software -
See separate section on CAM2 Software below |
The
Faro Scan Arm. The Faro
Scan Arm is a Faro Arm equipped with a combination of a hard probe (like that in
the Faro Arm) and a
non-contact line laser probe. This product provides our customers the ability to
measure their products without touching them.
The
Faro Laser Tracker. A
combination of a portable, large-volume laser measurement tool, a touch screen
computer, and CAM2 software programs.
q |
Laser
Tracker -
The Faro Laser Tracker utilizes an ultra-precise laser beam to measure
objects of up to 230 feet. It enables manufacturing, engineering, and
quality control professionals to measure and inspect large parts, machine
tools and other large objects on-site and/or in-process. With its greater
angular resolution, repeatability, and accuracy, the Faro Laser Tracker
advances already-proven tracker technology. Among its many enhanced
features is SuperADM, which improves upon existing Absolute Distance
Measurement technology by providing the new time-saving ability to
reacquire the laser beam without the need to return to a known reference
point or the need to hold the target
stationary. |
q |
Touch
Screen Computer -
See description under Faro Arm above. |
q |
CAM2
Software --
See description below. |
The
Faro Gage. Sold as a
combination of an articulated arm device with a computer and software, the Faro
Gage is a smaller, higher accuracy version of the Faro Arm product. What
distinguishes the Faro Gage from just another size of the Faro Arm are the
special mounting features and the basic software which are unique to the Faro
Gage. The Faro Gage is targeted at machine tools, and bench tops around machine
tools, where basic measurements of smaller machined parts must be measured. As
such, the CAM2 software developed for this device features basic 2D and 3D
measurements common to these applications. The FARO Gage was introduced in May
2003. (See also “Faro Gage Software” below.)
CAM2
Software. CAM2
is the Company's family of proprietary CAD-based measurement and statistical
process control software. The CAM2 product line includes six software programs,
many of which are translated into seven languages:
q |
CAM2
CAD Analyzer
allows users to convert very large, complex CAD files from engineering
workstations into simpler graphical images which make them available on a
personal computer level for numerous applications throughout the factory
from assembly and inspection planning, to the creation of user or service
manuals. |
5
q |
CAM2
Measure allows
users to compare measurements of manufactured components or assemblies
with the corresponding CAD data for the components or assemblies.
CAM2
Measure is offered with the Faro Arm and the Faro Laser Tracker.
|
q |
CAM2
Automotive also
allows users to compare measurements of manufactured components with the
corresponding CAD file. Unlike CAM2
Measure, CAM2
Automotive is especially suited to the measurement of very large
components with large CAD files, typical of those in the automotive
industry. CAM2
Automotive is offered with the Faro Arm and Faro Laser Tracker.
|
q |
CAM2
SPC Process
allows for
the collection, organization, and presentation of measurement data
factory-wide. Not limited to measurements from the Faro Arm or Faro Laser
Tracker, CAM2
SPC Process accepts data from CMM and other computer-based measurement
devices from many different measurement applications along the production
line. |
q |
Soft
Check Tool is
a custom software program designed to lead an operator through a
measurement process on the Faro Arm or Faro Laser Tracker with minimal
training. These programs are created by the Company from specifications
provided by the customer. |
q |
Faro
Gage Software includes
a dedicated graphical interface designed for the ease of use of the
operator. Capable of producing graphical and tabular reports, the software
runs a library of gauging and Soft Check
tools. |
Customers
The
Company's products have been purchased by approximately 3,800 customers
worldwide, ranging from small machine shops to large manufacturing and
industrial companies. The Company's ten largest customers by revenue represented
an aggregate of 7.1% of the Company's total revenues in 2004. No customer
represented more than 2.0% of the Company's sales in 2004.
Sales
and Marketing
The
Company directs its sales and marketing efforts on a decentralized basis in
three main regions around the world: Americas, Europe/Africa and Asia/Pacific.
The regional headquarters for the Americas is in the Company’s headquarters in
Lake Mary, Florida and the Europe/Africa regional headquarters is in Stuttgart,
Germany. The Company intends to open regional headquarters for the Asia/Pacific
region in Singapore in 2005. At December 31, 2004 the Company employed 54, 76,
and 37 sales and marketing specialists in the Americas, Europe/Africa, and
Asia/Pacific regions, respectively. The Company has direct sales representation
in the United States, Canada, Brazil, Germany, United Kingdom, France, Spain,
Italy, India, South Korea, China and Japan. See Footnote 20 to the Notes to
Consolidated Financial Statements, incorporated herein by reference to Item 8
hereof, for financial information about the Company's foreign and domestic
operations and export sales required by this Item.
The
Company uses a process of integrated lead qualification and sales demonstration.
Once a customer opportunity is identified, the Company employs a team-based
sales approach involving inside and outside sales personnel who are supported by
application engineers. The Company employs a variety of marketing techniques to
promote brand awareness and customer identification.
6
Research
and Development
The
Company believes that its future success depends on its ability to maintain
technological leadership, which will require ongoing enhancements of its
products and the development of new applications and products that provide 3-D
measurement solutions. Accordingly, the Company intends to continue to make
substantial investments in the development of new technologies, the
commercialization of new products that build on the Company's existing
technological base, and the enhancement and development of additional
applications for its products.
The
Company's research and development efforts are directed primarily at enhancing
the functional adaptability of its current products and developing new and
innovative products that respond to specific requirements of the emerging market
for 3-D measurement systems. The Company's research and development efforts have
been devoted primarily to mechanical hardware, electronics and software. The
Company's engineering development efforts will continue to focus on enhancing
our existing products and developing new products for the CAM2
market.
At
December 31, 2004, the Company employed 43 scientists
and technicians in its research and development efforts. Research and
development expenses were approximately $5.4 million in 2004 as compared to $4.5
million in 2003 and $4.0 million in 2002. We believe that the continual
development or acquisition of innovative new products is critical to our future
success. The field of CAM2 and more broadly, 3-D measurement, continues to
expand and new technologies and applications will be essential to competing in
this market.
Research
and development activities, especially with respect to new products and
technologies, are subject to significant risks, and there can be no assurance
that any of the Company's research and development activities will be completed
successfully or on schedule, or, if so completed, will be commercially
accepted.
Intellectual
Property
The
Company holds or has pending 74 patents in the United States and related patents
worldwide. The Company also has 10 registered trademarks in the United States
and worldwide, 1 foreign registered trademark, 4 trademark applications pending
in the United States and 5 foreign trademark applications pending.
The
Company relies on a combination of contractual provisions and trade secret laws
to protect its proprietary information. There can be no assurance that the steps
taken by the Company to protect its trade secrets and proprietary information
will be sufficient to prevent misappropriation of its proprietary information or
preclude third-party development of similar intellectual property.
Despite
the Company's efforts to protect its proprietary rights, unauthorized parties
may attempt to copy aspects of the Company's products or to obtain and use
information that the Company regards as proprietary. The Company intends to
vigorously defend its proprietary rights against infringement by third parties.
However, policing unauthorized use of the Company's products is difficult,
particularly overseas, and the Company is unable to determine the extent to
which piracy of its software products exists. In addition, the laws of some
foreign countries do not protect the Company's proprietary rights to the same
extent as the laws of the United States.
The
Company does not believe that any of its products infringe on the proprietary
rights of third parties. There can be no assurance, however, that third parties
will not claim infringement by the Company with respect to current or future
products. Any such claims, with or without merit, could be time-consuming,
result in costly litigation, cause product shipment delays or require the
Company to enter into royalty or licensing agreements. Such royalty or licensing
agreements, if required, may not be available on terms acceptable to the Company
or at all, which could have a material adverse effect upon the Company's
business, operating results and financial condition.
7
Manufacturing
and Assembly
The
Company manufactures its products at its headquarters in Lake Mary, Florida, and
at its plants in Kennett Square, Pennsylvania and Schaffhausen, Switzerland.
Manufacturing consists primarily of assembling finished products with components
and subassemblies, purchased from suppliers, into finished products. The primary
components, which include machined parts and electronic circuit boards, are
produced by subcontractors according to the Company’s specifications. All
products are assembled, calibrated and tested for accuracy and functionality
before shipment. In limited circumstances, the Company performs in-house circuit
board assembly and part machining.
The
Company's manufacturing, engineering, and design headquarters have been
registered to the ISO-9001 standard since July 1998. Semi-annual surveillance
audits have documented continuous improvement to this multinational standard.
The Company continues to examine its scope of registration as the business
evolves and has chosen English as the standard business language for its
operations. This decision is expected to significantly influence the Company’s
operations and documentation globally. This has been done in concert with the
ISO Standard Registrar, and is expected to increase customer confidence in the
Company’s products and services worldwide.
The
Company takes a global approach to ISO registration, seeking to have all
locations registered with identical scope of accreditation and capabilities for
the products generated and serviced. In 2004 FARO took this to the highest level
possible. All manufacturing sites are now jointly registered to ISO-9001:2000.
In addition, all service sites (United States, Germany, Japan, China, Brazil)
have been jointly accredited to ISO-17025
for Calibration and Certification Laboratories by the Laboratory Accreditation
Bureau.
Competition
Our
portable measurement systems compete in the broad market for measurement devices
for manufacturing and industrial applications which, in addition to portable
articulated arms and laser tracker products, consist of fixed-base CMMs, check
fixtures, and handheld measurement tools. The broad market for measurement
devices is highly competitive. In the Faro Gage product line, manufacturers of
handheld measurement tools and fixed-base CMMs include a significant number of
well-established companies that are substantially larger and possess
substantially greater financial, technical, and marketing resources than we
possess. In the Faro Arm and Faro Scan Arm product lines, we compete with
Hexagon Metrology, a division of Hexagon. Hexagon is significantly larger
than us. In the Faro Laser Tracker product line, we compete primarily with Leica
Geosystems, a division of Leica. Leica is significantly larger than
us. We will be required to make continued investments in technology and product
development to maintain our technological advantage over our competition. We
cannot assure you that we will have sufficient resources to make additional
investments in technology and product development or that our product
development efforts will allow us to successfully compete as the industry
evolves.
As the
market for laser trackers and our portable coordinate measurement machines
expands, additional competition may emerge and the Company’s existing and future
competitors may commit more resources to the markets in which the Company
participates.
The
worldwide trend toward CAD-based factory floor metrology has resulted in the
introduction of CAD-based inspection software and statistical process control
for conventional CMMs by most of the large CMM manufacturers. Certain CMM
manufacturers are miniaturizing, and in some cases increasing the mobility of,
their conventional CMMs. Nonetheless, these CMMs still have small measurement
volumes, lack the adaptability typical of portable, articulated arm measurement
devices, and lose accuracy outside the controlled environment of the metrology
lab.
8
Backlog
At
December 31, 2004, the
Company had orders representing approximately $5.1
million in
product sales outstanding. The majority of these specific orders were shipped by
March 7, 2005, and, as of March 7, 2005, the Company had orders representing
approximately $6.9 million in
product sales outstanding. At December 31, 2003 and 2002, the Company had orders
representing approximately $7.5 million and $8.8 million in product sales
outstanding, respectively.
The
Company’s decreased backlog is the
result of increased production of its laser tracker and articulated arm product
lines in 2004
to meet customer demand. The Company believes that substantially all of the
outstanding sales orders as of March 7, 2005 will be shipped during 2005.
Employees
At
December 31, 2004, the Company had 453 full-time employees, consisting of
167 sales and marketing professionals, 95 production staff, 43 research and
development staff, 66 administrative staff, and 82 customer service/application
engineering specialists. The Company is not a party to any collective bargaining
agreements. The Company believes its employee relations are good. Management
believes that its future growth and success will depend in part on its ability
to retain and continue to attract highly skilled personnel. The Company
anticipates that it will be able to obtain the additional personnel required to
satisfy its staffing requirements over the foreseeable future.
Available
Information
We
maintain a web site with the address www.faro.com. Information contained on our
web site is not a part of, or incorporated by reference into, this Annual Report
on Form 10-K. We make available free of charge through our web site our
Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, proxy statements and amendments to these reports, as
soon as reasonably practicable after we electronically file these reports with,
or furnish these reports to, the Securities and Exchange Commission.
We were
organized in 1982 and are incorporated in Florida.
Management
of the Registrant
The
officers and key management personnel of the Company are as follows:
Name | Age | Principal Position |
Simon
Raab, Ph.D. |
52 |
Chairman
of the Board, Chief Executive Officer |
Jay
W. Freeland |
35 |
President
and Chief Operating Officer |
Barbara
R. Smith |
45 |
Chief
Financial Officer |
Gregory
A. Fraser, Ph.D. |
49 |
Executive
Vice President, Secretary, and Treasurer |
Joanne
M. Karimi |
46 |
Senior
Vice President of Operations |
Robert
P. Large |
55 |
Vice
President of Sales |
Allen
Sajedi |
45 |
Vice
President and Chief
Technical Officer |
Wendelin
K.
J. Scharbach |
49
|
Co-Managing
Director of FARO Europe |
Siegfried
K. Buss |
39
|
Co-Managing
Director of FARO Europe |
Simon
Raab, Ph.D., a
co-founder of the Company, has served as the Chairman of the Board, Chief
Executive Officer and a director of the Company since its inception in 1982. Mr.
Raab holds a Ph.D. in Mechanical Engineering from McGill University, Montreal,
Canada, a Masters of Engineering Physics from Cornell University and a Bachelor
of Science in Physics with a minor in Biophysics from the University of
Waterloo, Canada.
9
Jay
W. Freeland has
served as President and Chief Operating Officer of the Company since November
2004. Prior to that Mr. Freeland was president of his own consulting company
from 2002 until 2004. Mr.
Freeland began his career at General Electric (GE-NYSE) in their financial
management program in 1991, spent four years on their corporate audit staff and
served in financial, business development, sales and operational management
roles of increasing responsibility until 2002. Mr. Freeland holds a Bachelor of
Arts in Economics from Union College, Schenectady, New York.
Barbara
R. Smith has
served as Chief Financial Officer of the Company since February 2005. Prior to
that Ms. Smith served as Vice President, Finance of Alcoa’s (AA-NYSE) aerospace,
automotive and commercial transportation group, Cleveland, Ohio. Ms. Smith has
held senior financial management positions at Alcoa since 1993, after joining
that company in 1981. Ms. Smith
holds a Bachelor of Science in Accounting degree from Purdue University, West
Lafayette, Indiana.
Gregory
A. Fraser, Ph.D., a
co-founder of the Company, has served as Executive Vice President, Secretary,
and Treasurer since February 2005. Prior to that Mr. Fraser served as Chief
Financial Officer and Executive Vice President since May 1997 and as Secretary,
Treasurer and a director of the Company since its inception in 1982. Mr. Fraser
holds a Ph.D. in Mechanical Engineering from McGill University, Montreal,
Canada, a Masters of Theoretical and Applied Mechanics from Northwestern
University and a Bachelor of Science and Bachelor of Mechanical Engineering from
Northwestern University.
Joanne
M. Karimi has
served as Senior Vice President of Operations since November 2004. Prior to that
Ms. Karimi served as Vice President of Human Resources of the Company since July
2001 and as Director of Human Resource Systems since October 1998. Prior to
that, Ms. Karimi served as Director of Human resources of the Disney Vacation
Club, a unit of The Walt Disney Company (DIS-NYSE). Ms. Karimi holds an MBA and
a Bachelor of Business Management degree from the University of West
Florida.
Robert
P. Large has
served as Vice President of Sales since June 2001. Prior to that, Mr. Large was
Vice President of Sales of the Hill - Rom Company, a division of Hillenbrand
Industries, Batesville, Indiana (HB-NYSE). Mr. Large has held upper management
positions in sales and marketing with Hillenbrand, as well as Biomet Corp.
(BMET-NASDAQ), OEC Co., and AHS Corp. Mr. Large holds a Bachelor of Business
Management degree from Baldwin - Wallace College, Berea, Ohio and attended New
England School of Law, Boston, Massachusetts and Western New England School of
Law, Springfield, Massachusetts.
Allen
Sajedi has
served as Vice President and Chief Technical Officer since 2002 and as Chief
Engineer of the Company since 1990. Mr. Sajedi holds a Bachelor’s Degree in
Mechanical
Engineering from
McGill
University, Montreal, Canada.
Wendelin
K.
J. Scharbach, a
co-founder of CATS
GmbH, a
predecessor of FARO Europe, the Company’s principal subsidiary in Europe, has
served as Co-managing Director of FARO Europe since May 1998. Prior to that Mr.
Scharbach
was Managing Director of CATS GmbH. Mr. Scharbach holds a Bachelor´s degree in
Mechanical Engineering from Fridriciana University, Karlsruhe,
Germany.
Siegfried
K. Buss, a
co-founder of CATS
GmbH, a
predecessor of FARO Europe, the Company’s principal subsidiary in Europe, has
served as Co-managing Director of FARO Europe since May 1998. Prior to that Mr.
Buss was
Managing Director of CATS GmbH.
10
Item
2.
Properties.
The
Americas
The
Company's headquarters are located in a leased building in Lake Mary, Florida
containing approximately 35,000 square feet. This facility houses the Company’s
U.S. production, research and development, administrative staff and customer
service/application operations. The Company’s U.S. sales and marketing
headquarters is in a leased building in Lake Mary, Florida consisting
approximately 8,200 square feet. Additionally, the Company has a leased facility
consisting of 20,800 square feet located in Kennett Square, Pennsylvania
containing research and development and manufacturing operations of the laser
tracker product lines.
Europe/Africa
The
Company’s European headquarters are located in a leased building in Stuttgart,
Germany containing approximately 19,500 square feet. This facility houses the
administration, sales, marketing and service management personnel for the
Company’s European operations. Additionally the Company has a leased facility
consisting of 15,930 square feet located in Schaffhausen, Switzerland containing
manufacturing operations for the Company’s products, which are shipped to
customers in Europe, Africa and Asia.
Asia/Pacific
The
Company’s Japan headquarters are located in a leased building in Nagoya, Japan
containing 5,200 square feet. This facility houses the Company’s Japan sales,
marketing and service operations. The Company’s China headquarters are located
in a leased building in Shanghai, China containing 11,500 square feet for sales,
marketing and service operations.
The
Company believes that its current facilities will be adequate for its
foreseeable needs and that it will be able to locate suitable space for
additional regional offices or enhanced production needs as necessary.
The
information required by the remainder of this Item is incorporated herein by
reference to Exhibit 99.1 attached hereto.
Item
3.
Legal Proceedings.
The
Company is not a party to any material pending legal proceedings other than
ordinary routine litigation incidental to the Company’s business. The
Company is subject to various claims and contingencies related to lawsuits
arising out of the normal course of business. The
Company believes
that the ultimate outcome of any pending legal proceeding, even if the outcome
were unfavorable to the Company, is not likely to have a materially adverse
effect on the Company's business, financial condition or results of
operations.
Item
4.
Submission of Matters to a Vote of Security Holders.
No
matters were submitted to a vote of security holders during the last quarter of
calendar 2004.
11
PART
II
Item
5.
Market For Registrant's Common Equity and Related Stockholder
Matters.
The
Company’s common stock, par value $.001 per share, began trading on the NASDAQ
Stock Market in September 1997 under the symbol FARO. Before that date, there
was no established public trading market for the common stock. The following
table sets forth the high and low sale price of the Company’s common stock for
its two most recent fiscal years:
2004 |
|
|
2003 |
| |||||||||
|
|
|
High |
|
|
Low |
|
|
High |
|
|
Low |
|
First
Quarter |
33.23
|
20.27
|
3.31
|
1.91
|
|||||||||
Second
Quarter |
27.89
|
17.63
|
7.72
|
3.12
|
|||||||||
Third
Quarter |
24.60
|
18.62
|
13.53
|
6.67
|
|||||||||
Fourth
Quarter |
31.85
|
20.55
|
30.20
|
12.10
|
The
Company has not paid any cash dividends on its common stock to date. The payment
of dividends, if any, in the future is within the discretion of the Board of
Directors and will depend on the Company’s earnings, its capital requirements
and financial condition, and may be restricted by future credit arrangements
entered into by the Company. The Company expects to retain future earnings for
use in operating and expanding its business and does not anticipate paying any
cash dividends in the reasonably foreseeable future. As of March 10, 2005, the
last sale price of the Company’s common stock was $22.85, and there were
approximately 77 holders of record of common stock. The Company believes that
there are approximately 1,300 beneficial owners of its common
stock.
On
November 12, 2003, the Company sold 1,158,000 shares of its common stock, and
two of the Company’s founders sold 772,000 shares of the Company’s common stock
to institutional investors in a private placement that was not registered under
the Securities Act of 1933. The shares were sold for $21.50 per share, resulting
in total proceeds before placement agent fees and other offering expenses of
$24.9 million and $16.6 million to the Company and the co-founders,
respectively. The purchasers of the shares sold in the transaction were 31
institutional investors. Robert W. Baird & Co. served as the placement agent
for the transaction, and received a fee equal to $2,489,700, or 6% of the
aggregate sales proceeds. The Company also reimbursed Robert W. Baird & Co.
for $50,000 in expenses incurred in connection with the transaction. The
private placement transaction was exempt from registration under the Securities
Act of 1933, as amended, pursuant to section 4(2) thereof and Rule 506 under
Regulation D promulgated by the Securities and Exchange Commission there under.
These exemptions were available for the private placement transaction on the
basis that the transaction did not involve a public offering and satisfied each
of the criteria under Rule 506 of Regulation D.
12
Item
6.
Selected Financial Data.
|
Historical
- Year ended December 31, |
||||||||||||||||
2004 |
|
|
2003 |
|
|
|
2002 |
|
|
2001 |
|
|
2000 |
||||
Statement
of Operations Data: |
|||||||||||||||||
Sales |
$ |
97,019,875 |
$ |
71,785,980 |
$ |
46,246,372 |
$ |
36,121,696 |
$ |
40,912,663 |
|||||||
Gross
profit |
59,996,171
|
42,265,731
|
25,136,763
|
21,817,613
|
26,164,035
|
||||||||||||
Income
(loss) from operations |
14,583,832
|
7,440,135
|
(2,939,243 |
) |
(3,361,610 |
) |
(237,350 |
) | |||||||||
Income
(loss) before income taxes |
15,289,165
|
9,435,270
|
(1 |
) |
(1,804,831 |
) |
(2,506,226 |
) |
464,198
|
||||||||
Net
income (loss) |
14,930,874
|
8,277,740
|
(2,015,571 |
) |
(2,847,964 |
) |
39,517
|
||||||||||
Net
income (loss) per common share: |
|||||||||||||||||
Basic |
$ |
1.08 |
$ |
0.68 |
$ |
(0.17 |
) |
$ |
(0.26 |
) |
$ |
- |
|||||
Diluted |
$ |
1.06 |
$ |
0.64 |
$ |
(0.17 |
) |
$ |
(0.26 |
) |
$ |
- |
|||||
Weighted
average common shares outstanding: |
|||||||||||||||||
Basic |
13,833,590
|
12,181,221
|
11,853,732
|
11,032,449
|
11,021,606
|
||||||||||||
Diluted |
14,023,159
|
12,845,992
|
11,853,732
|
11,032,449
|
11,094,144
|
||||||||||||
|
Historical - Year ended December
31, |
||||||||||||||||
2004 |
|
|
2003 |
|
|
|
2002 |
|
|
2001 |
|
|
2000 |
||||
Consolidated
Balance Sheet Data: |
|||||||||||||||||
Working
capital |
$ |
65,687,143 |
$ |
51,368,302 |
$ |
18,338,541 |
$ |
22,303,204 |
$ |
23,672,736 |
|||||||
Total
assets |
105,078,361
|
81,913,888
|
45,194,780
|
39,654,124
|
44,699,274
|
||||||||||||
Total
debt |
249,410
|
107,234
|
1,556,125
|
80,626
|
66,657
|
||||||||||||
Total
shareholders’ equity |
89,158,561
|
68,921,099
|
33,383,649
|
32,336,461
|
35,955,453
|
||||||||||||
(1)
Includes a favorable legal settlement of $1.1 million in other
income. |
Item
7.
Management’s Discussion and Analysis of Financial Condition and Results of
Operations.
The
following information should be read in conjunction with the Consolidated
Financial Statements of the Company, including the notes thereto, included
elsewhere in this document.
Overview
We
design, develop, market and support portable, software-driven, 3-D measurement
systems that are used in a broad range of manufacturing and industrial
applications. Our principal products are the Faro Arm and Faro Gage articulated
arm measuring devices, the Faro Laser Tracker, a laser-based measuring device,
and their companion CAM2 software, which provide for CAD-based inspection and
factory-level statistical process control. In the first half of 2004, we
introduced a new non-contact laser probe option for the Faro Arm. When sold
together, this combination of the Faro Arm and its laser probe option is called
the Faro Scan Arm. Together, all of these products integrate the measurement and
quality inspection function with CAD software to improve productivity, enhance
product quality and decrease rework and scrap in the manufacturing process. Our
products bring precision measurement, quality inspection and specification
conformance capabilities, integrated with leading CAD software, to the factory
floor. We are a pioneer in the development and marketing of 3-D measurement
technology in manufacturing and industrial applications and currently hold 39
patents. Our products have been purchased by more than 3,800 customers
worldwide, ranging from small machine shops to such large manufacturing and
industrial companies as Audi, Bell Helicopter, Boeing, British Aerospace,
Caterpillar, Daimler Chrysler, General Electric, General Motors, Honda, Johnson
Controls, Komatsu Dresser, Lockheed Martin, Siemens and Volkswagen among many
others.
13
We
continue to pursue international markets. We established sales offices in France
and Germany in 1996, Great Britain in 1997, Japan and Spain in 2000, Italy in
2001, and China in 2003. We opened sales offices in South Korea and India in the
fourth quarter of 2004. In 2003 we began to manage and report our global sales
in three regions: the Americas, Europe/Africa and Asia/Pacific. In 2004 43.0% of
our sales were in the Americas compared to 52.7% in 2003, 44.4% were in the
Europe/Africa region compared to 38.6% in 2003 and 12.6% were in the
Asia/Pacific region, compared to 8.7% in 2003 (see also Note 20 Geographic Data
to the financial statements below). Although we expect variations in the
percentage of our sales in the Asia/Pacific region from quarter to quarter going
forward, we generally expect higher percentage sales growth in the Asia/Pacific
region than the other regions in 2005 and 2006 as a result of our new sales
offices in China, India and South Korea, and the addition of sales personnel and
the opening of a service center in our Japan office. We also expect to open an
Asia/Pacific regional headquarters in Singapore in 2005.
We derive
revenues primarily from the sale of our Faro Arm, Faro Scan Arm, Faro Gage and
Faro Laser Tracker 3-D measurement equipment, and its related multi-faceted CAM2
software. Revenue related to these products is recognized upon shipment. In
addition, we sell one and three-year extended warranties and training and
technology consulting services relating to our products. We recognize the
revenue from extended warranties proportionately, in the same manner as costs
are incurred for such revenues. We also receive royalties from licensing
agreements for our historical medical technology and generally recognize the
revenue from these royalties as licensees use the technology. Royalties from
licensing agreements were $817,000, $601,000 and $990,000 in 2004, 2003 and
2002, respectively.
In 2003,
we began to manufacture our Faro Arm products in Switzerland for customer orders
from the Europe/Africa and Asia/Pacific regions. We began to manufacture our
Faro Gage product, and parts of our Faro Laser Tracker product in our Swiss
plant in the third quarter of 2004. We expect to begin complete production of
the Faro Laser Tracker product in our Swiss plant in 2005. The production of
these products for customer orders from the Americas will be done in our
manufacturing facilities located in Florida and Pennsylvania. We expect all our
existing plants to have the production capacity necessary to support our growth,
at least through 2006.
Cost of
sales consists primarily of material, production overhead and labor. Since our
IPO in 1997, annual gross margin has been in the range of 54%-64% of sales. We
have established a goal of maintaining target full year ranges in 2005 for gross
margin between 59% and 62% and operating margin between 14.5% and 18.5%. Gross
margin for fiscal 2004 was within that range at 61.8%, although gross margin for
the fourth quarter of 2004 was below that range at 58.0% partly as a result of a
higher proportion of sales coming from demonstration equipment which carry lower
margins.
Selling
expenses as a percentage of sales grew slightly in 2004 to 26.7% compared to
25.6% in 2003. The higher percentage in 2004 was due to the addition of new
sales personnel in the Asia/Pacific region resulting in higher costs while the
additional sales people become fully trained and productive. We have established
a goal of maintaining selling expenses as a percentage of sales at
25%.
General
and administrative expenses consist primarily of salaries for administrative
personnel, rent, utilities and professional and legal expenses. General and
administrative expenses were higher in the second half of 2004 due in part to an
increase in professional and legal expenses of approximately $670,000 directly
related to our compliance with Sarbanes-Oxley section 404 regarding internal
controls and procedures. We expect this amount to be approximately $500,000 in
2005. Notwithstanding the expected higher ongoing costs of compliance with new
laws and regulations governing public companies in the United States, we expect
general and administrative expenses to gradually drop to approximately 10% of
sales as higher sales should not require a proportionate increase in these
expenses. Research and development expenses represent salaries, equipment and
third-party services. We have a commitment to support ongoing research and
development and intend to continue to fund these efforts at the level of 5-7% of
sales going forward.
14
We expect
to incur expenses of approximately $2 million in 2005 as calculated under the
Black-Scholes method of FAS 123, related to our expected adoption of FAS 123(R)
for the expensing of stock options. We are investigating other valuation methods
for these expenses prior to our adoption of FAS 123(R). These expenses will be
apportioned according to the employees who have received stock options into cost
of sales, selling, general and administrative or research and development
costs.
In 2003
and 2004 we have been able to use previously reserved net operating loss
carry-forwards, which have reduced our effective tax rate to 12.3% in 2003 and
2.3% in 2004. We have also received a favorable permanent income tax rate
commitment from the Swiss government as an incentive to establish a
manufacturing plant in Switzerland. We are not providing deferred tax assets on
temporary differences scheduled to reverse after the commitment period because
all of its earnings are included in the current tax provision. By the second
quarter of 2005 we expect that approximately 60% of our total shipments will
come from the Swiss plant. These shipments will be to Europe/Africa and the
Asia/Pacific regions. As a
result we expect the blended (consolidated) tax rate to be 20% for 2005, and
this could fluctuate depending upon, among other things, our ability to use more
previously reserved net operating loss carry-forwards and the amount of our
sales in Europe and shipments from our Swiss plant. See "Critical Accounting
Policies - Income Taxes" below.
Accounting
for wholly owned foreign subsidiaries is maintained in the currency of the
respective foreign jurisdiction and, therefore, fluctuations in exchange rates
may have an impact on inter-company accounts reflected in our consolidated
financial statements. We are aware of the availability of off-balance sheet
financial instruments to hedge exposure to foreign currency exchange rates,
including cross-currency swaps, forward contracts and foreign currency options
(see Foreign Exchange Exposure below). However, we do not regularly use such
instruments, and none were utilized in 2004 or 2003.
We have
had ten consecutive profitable quarters through December 31, 2004. This followed
a period of losses in 2001 and the first half of 2002, which resulted from an
economic slowdown in manufacturing in 2001, and expenses arising from the
acquisition in January 2002 of SpatialMetriX Corporation (SMX). Our sales growth
and return to profitability since then was a result of a number of factors
including the acquisition of SMX, which manufactured the predecessor to the Faro
Laser Tracker, the introduction in October 2002 of the latest generation of our
traditional Faro Arm product, the introduction of the Faro Gage in September
2003, the introduction of our Faro Scan Arm product in 2004, and an increase in
the number of sales people worldwide. Our worldwide sales and marketing
headcount in 2004, 2003 and 2002 was 167, 120, and 106,
respectively.
In the
third quarter of 2003 the Company recorded approximately $1.1 million in other
income as a result of receiving approximately 100,000 shares of Company stock
related to a positive arbitration settlement between the Company and the former
SMX shareholders.
On
November 12, 2003, we sold 1,158,000 shares of common stock to certain
institutional investors in a private placement. The shares were sold for $21.50
per share, resulting in total proceeds before placement agent fees and other
offering expenses of $24.9 million. This transaction significantly increased our
cash available for a variety of potential uses including working capital,
acquisitions, capital expenditures and our ongoing international expansion. See
also “Liquidity and Capital Resources”.
15
Results
of Operations
The
following table sets forth for the periods presented, the percentage of sales
represented by certain items in the Company’s consolidated statements of
operations:
|
Year
ended December 31, |
| ||||||||
|
|
|
2004 |
|
|
2003 |
|
|
2002 |
|
Statement
of Operations Data: |
||||||||||
Sales |
100.0 |
% |
100.0 |
% |
100.0 |
% | ||||
Cost
of Sales |
38.2 |
% |
41.1 |
% |
45.6 |
% | ||||
Gross
profit |
61.8 |
% |
58.9 |
% |
54.4 |
% | ||||
Operating
expenses: |
||||||||||
Selling |
26.7 |
% |
25.6 |
% |
30.0 |
% | ||||
General
and administrative |
12.1 |
% |
13.7 |
% |
17.0 |
% | ||||
Depreciation
and amortization |
2.4 |
% |
3.0 |
% |
5.0 |
% | ||||
Research
and development |
5.6 |
% |
6.3 |
% |
8.7 |
% | ||||
Total
operating expenses |
46.8 |
% |
48.5 |
% |
60.7 |
% | ||||
Income
(loss) from operations |
15.0 |
% |
10.4 |
% |
(6.3 |
)% | ||||
Interest
income |
0.4 |
% |
0.1 |
% |
1.2 |
% | ||||
Other
income, net |
0.4 |
% |
2.7 |
% |
1.3 |
% | ||||
Interest
expense |
0.0 |
% |
(0.1 |
)% |
(0.1 |
)% | ||||
Income
(loss) before income taxes |
15.8 |
% |
13.1 |
% |
(3.9 |
)% | ||||
Income
tax expense |
0.4 |
% |
1.6 |
% |
0.5 |
% | ||||
Net
income (loss) |
15.4 |
% |
11.5 |
% |
(4.4 |
)% | ||||
2004
Compared to 2003
Sales.
Sales increased $25.2 million or 35.1% from $71.8 million for the
year ended December 31, 2003 to $97.0 million for year ended December 31, 2004.
This increase resulted from higher unit sales of the Faro Arm, Faro Laser
Tracker and Faro Gage products, and an overall increase in headcount in sales
and marketing of 47, or 39.2% from 120 in 2003 to 167 in 2004. Geographically,
sales increased $3.8 million or 10.0% in the Americas, $15.4 million or 55.6% in
Europe/Africa, and $6.0 million or 96.8% in the Asia/Pacific region. Our sales
growth is driven to a large extent by the growth in the number of sales people
we have. We expect that new sales people will have a learning curve of 3-6
months before they are fully functional. In 2004 our sales and marketing
headcount increased 23% from 44 to 54 in the Americas, 13% from 67 to 76 in
Europe /Africa, and 311% from 9 to 37 in the Asia/Pacific region.
Gross
profit.
Gross profit increased $17.7 million or 41.8% from $42.3 million for
the year ended December 31, 2003 to $60.0 million for the year ended December
31, 2004. Gross margin increased from 58.9% for the year ended December 31, 2003
to 61.8% for the year ended December 31, 2004 due to reduced price discounts,
reduced service costs as a percentage of sales from 9.0% in 2003 to 8.5% in
2004, as a result of improvements in product quality and efficiencies in
production.
16
Selling
expenses.
Selling expenses increased by $7.6 million or 41.5%, from $18.3
million for the year ended December 31, 2003 to $25.9 million for the year ended
December 31, 2004. This increase was a result of higher commissions of $3.0
million, higher salaries and bonuses of $2.5 million, higher product
demonstration costs of $1.2 million and higher marketing costs of $0.9 million.
As a percentage of sales, selling expenses increased to 26.7% of sales in 2004
from 25.6% in 2003.
General
and administrative expenses.
General and administrative expenses increased by $1.9 million or
19.4% from $9.8 million for the year ended December 31, 2003 to $11.7 million
for the year ended December 31, 2004. This increase was due to higher salaries
and bonuses of $1.4 million, higher professional and legal fees of $787,000 and
higher facilities and rent of $349,000, partially offset by reduced stock option
expense of $441,000. General and administrative expenses as percentage of sales
fell to 12.1% of sales in 2004 from 13.7% of sales in 2003. In filings prior to
Form 10-Q for the third quarter of 2004 we represented the cost of employee
stock options as a separate line item in our consolidated statements of
operations. In accordance with SEC Regulation S-X we have eliminated the
separate line item for all periods presented, and have included the cost of
employee stock options in the appropriate expense category, according to each
employee’s function. Virtually all of the employees who had stock options that
gave rise to an expense were in administration. As a result, the $9.8 million in
general and administration expenses for 2003 reported above is higher than the
$9.1 million previously reported in our Form 10-K for 2003 by $0.7 million in
employee stock option expense in 2003.
Depreciation
and amortization expenses.
Depreciation and amortization expenses increased by $220,000 or
10.5% from $2.1 million for the year ended December 31, 2003 to $2.3 million in
2004, due to an
increase in depreciation of new equipment and capital leases.
Research
and development expenses.
Research and development expenses increased by $910,000 or 20.2%
from $4.5 million for the year ended December 31, 2003 to $5.4 million for the
year ended December 31, 2004. This was due to an increase in salaries and
bonuses of $660,000 and an increase in external services and other project
expenses of $250,000. Research and development expenses as a percentage of sales
were 5.6% in 2004 compared to 6.3% in 2003.
Interest
income / expense.
Interest income increased by $274,000 or 334% from $82,000 for the
year ended December 31, 2003 to $356,000 for the year ended December 31, 2004
primarily from an increase in investments in 2004 related to the proceeds from
the Company’s sale of stock in November 2003 (see also Overview above
and Liquidity
and Capital Resources below).
Interest expense decreased by $34,000 from $46,000 for the year ended December
31, 2003 to $12,000 for the year ended December 31, 2004 (See Liquidity
and Capital Resources below).
Other
income, net.
Other
income, net decreased by $1.6 million from $2.0 million for the year ended
December 31, 2003 to $0.4 million for the year ended December 31, 2004. This
decrease was primarily due to a settlement of litigation with the former
shareholders of SMX for $1.1 million in 2003 (see also Note 2 - Acquisition) and
a reduction in foreign exchange gains of $153,000 in 2004.
Income
tax expense.
Income tax expense decreased $0.8 million from $1.2 million for the year ended
December 31, 2003 to $358,000 for the year ended December 31, 2004. The
effective tax rate in 2004 was 2.3% of income before income tax compared to
12.3% in 2003. The primary reason for the lower than expected tax rate was the
tax benefit attributable to a reduction in the valuation allowance of
approximately $3.2 million. Of that reduction, $1.5 million relates to usage of
“net operating losses” in foreign jurisdictions and $1.7 million of the
reduction in the valuation allowance relates to the partial release of the
valuation allowance taken in the fourth quarter on foreign deferred tax assets
which the Company now believes are more likely than not to be realized. The
Company determined that the amount of deferred tax assets relating to the net
operating loss carryforwards of foreign subsidiaries was understated by
approximately $3.7 million at December 31, 2003. As these net operating loss
carryforwards were fully reserved at December 31, 2003 by a valuation allowance,
there is no income statement or balance sheet impact to be recognized for 2003.
The Company has $5.0 million in net deferred tax assets remaining, which will
more likely than not be realized in 2005 and thereafter if the Company remains
consistently profitable (See also Note 14-Income Taxes). Separate from income
tax expenses, the Company recorded an addition to shareholders’ equity of $2.4
million for the income tax benefit received from the exercise of unqualified
stock options by employees.
17
Net
income (loss). Net
income increased $6.6 million or 79.5% from $8.3 million for the year ended
December 31, 2003 to $14.9 million for the year ended December 31, 2004 as a
result of the factors described above.
2003
Compared to 2002
Sales. Sales
increased $25.6 million or 55.4% from $46.2 million for the year ended December
31, 2002 to $71.8 million for year ended December 31, 2003. The increase
resulted from higher unit sales of the Faro Arm and Laser Tracker products, an
increase in headcount in sales and marketing from 106 in 2002 to 120 in 2003 and
from a 15% average price increase on existing products on January 1,
2003. Geographically,
sales increased $15.4 million or 68.5% in the Americas, $9.2 million or 49.8% in
Europe/Africa and $0.9 million or 17.8% in the Asia/Pacific region.
Gross
profit. Gross
profit increased by $17.1 million or 68.1% from $25.1 million for the year ended
December 31, 2002 to $42.2 million for the year ended December 31, 2003. Gross
margin percentage increased from 54.4% for the year ended December 31, 2002 to
58.9% for the year ended December 31, 2003 due to higher selling prices and
efficiencies in the Faro Laser Tracker manufacturing plant output.
Selling
expenses. Selling
expenses increased by $4.4 million or 31.7% from $13.9 million for the year
ended December 31, 2002 to $18.3 million for the year ended December 31, 2003.
This increase was a result of increased sales head count and higher commissions
due to higher sales. As a percentage of sales, selling expenses dropped to 25.6%
of sales in 2003 from 30.0% in 2002.
General
and administrative expenses. General
and administrative expenses increased by $1.9 million or 24.1% from $7.9 million
for the year ended December 31, 2002 to $9.8 million for the year ended December
31, 2003. The increase was primarily due to the increase in professional and
legal fees, stock option expense, service charges and network costs. General and
administrative expenses as a percentage of sales fell to 13.7% of the sales in
2003 from 17.0% of the sales in 2002.
Depreciation
and amortization expenses. Depreciation
and amortization expenses decreased by $149,000 or 6.5% from $2.3 million for
the year ended December 31, 2002 to $2.1 million in 2003 due to a
reduction in amortization of existing product technology of $374,000, offset by
an increase of $225,000 in depreciation of new equipment.
Research
and development expenses. Research
and development expenses increased by $497,000 or 12.4% from $4.0 million for
the year ended December 31, 2002 to $4.5 million for the year ended December 31,
2003 due primarily to the increased subcontractor costs and
materials. The
Company has a commitment to spend at least 5% of sales on research and
development.
Interest
income / expense. Interest
income decreased by $479,000 or 85.4% from $561,000 for the year ended December
31, 2002 to $82,000 for the year ended December 31, 2003 primarily from lower
average investments and lower interest rates in 2003. Interest expense increased
by $18,000 from $28,000 for the year ended December 31, 2002 to $46,000 for the
year ended December 31, 2003 due to increased use of a credit line (See
Liquidity
and Capital Resources below).
18
Other
income.
Other
income, net increased by $1.4 million from $601,000 for the year ended December
31, 2002 to $2.0 million for the year ended December 31, 2003 due primarily to
the settlement of litigation with the former shareholders of SMX for $1.1
million. (See also Note 2-Acquisition).
Income
tax expense.
Income tax expense increased by $947,000 from $211,000 for the year ended
December 31, 2002 to $1.2 million for the year ended December 31, 2003. The
effective tax rate in 2003 was 12.3% of income before income tax. The primary
reason for the relatively low tax rate was a reduction in the valuation
allowance of approximately $4.0 million. Of that reduction, $2.8 million relates
to usage of net operating losses in foreign jurisdictions and $1.2 million of
the reduction in valuation allowance relates to domestic assets for which the
Company now believes are more likely than not to be realized. The Company has
$1.7 million in deferred tax assets remaining, which may be recognized in 2004
if the Company remains consistently profitable. (See also Note 14-Income Taxes).
Separate from income tax expenses, the Company recorded an addition to
shareholders’ equity of $1.4 million for the income tax benefit received from
the exercise of unqualified stock options by employees.
Net
income (loss). The
results from operations increased by $10.3 million from a loss of $2.0 million
for the year ended December 31, 2002 to $8.3 million for the year ended December
31, 2003 as a result of the factors described above.
Liquidity
and Capital Resources
Since
1997, the Company had financed its operations primarily from cash provided by
operating activities and from the proceeds of its 1997 initial public offering
of common stock (approximately $31.7 million). On November 12, 2003 the Company
along with the Company's two co-founders completed a $41.5 million private
placement of its common stock with various institutional investors. Under the
terms of the agreement, the Company agreed to sell 1,158,000 shares, or
approximately 8% of total shares outstanding, and the two co-founders of the
Company, Simon Raab and Gregory Fraser, agreed to sell 772,000 shares, or
approximately 20% of their holdings, in the aggregate. The shares were sold for
$21.50 per share, resulting in total proceeds before placement agent fees and
other offering expenses of $24.9 million and $16.6 million to the Company and
the co-founders, respectively.
On
September 17, 2003, the Company entered into a loan agreement with SunTrust Bank
for a line of credit of $5 million. This agreement was renewed and is due to
mature on August 31, 2005. The facility bears an interest rate at LIBOR plus
1.75%. The Company has not drawn on this line of credit.
On
January 10, 2005, the Company filed a Registration Statement on Form S-3 with
the Securities and Exchange Commission allowing it to raise proceeds of up to
$125 million. The proceeds from any offerings with respect to this registration
statement, if any, would be used for either repayment or refinancing of debt,
acquisition of additional businesses or technologies or for working capital and
general corporate purposes.
For the
year ended December 31, 2004, net cash provided by operating activities
was $7.3
million compared
to $4.7
million in 2003.
The $2.6
million increase reflects growth in net income of $6.6 million, an increase in
income tax benefit from exercise of stock options of $1.0 million and the
absence of $1.1 million in other income realized in Company stock in the
settlement of the SMX litigation in 2003, partially offset by increases in
accounts receivable of $4.6 million, and deferred income tax benefit of $1.6
million.
19
Net cash
used by investing activities for the year ended December 31, 2004 was $9.9
million, compared to $15.2 million in 2003 primarily due to a reduction in net
investment purchases of $7.8 million.
Net cash
provided by financing activities for the year ended December 31, 2004 was $1.1
million compared to $23.0 million in 2003 due to a reduction in the proceeds
from issuance of stock of $23.2 million.
We
believe that our working capital, together with anticipated cash flow from our
operations, will be sufficient to fund our long-term liquidity requirements.
Contractual
Obligations and Commercial Commitments
The
Company is party to capital leases on automotive and other equipment with an
initial term of 36 to 60 months and other non-cancelable operating leases,
including leases with related parties that expire on or before 2009. These
obligations are presented below as of December 31, 2004:
|
Payments
Due by Period |
|||||||||||||||
Contractual
Obligations |
Total
|
|
|
<
1 Year |
|
|
1-3
Years |
|
|
3-5
Years |
|
|
>
5 Years |
|||
Capital
lease obligations |
$ |
249,410 |
$ |
103,713 |
$ |
145,697 |
$ |
- |
$ |
- |
||||||
Operating
lease obligations |
3,536,365
|
1,548,116
|
1,534,092
|
454,157
|
-
|
|||||||||||
Purchase
obligations |
4,356,498
|
4,356,498
|
-
|
-
|
-
|
|||||||||||
Total
|
$ |
8,142,273 |
$ |
6,008,327 |
$ |
1,679,789 |
$ |
454,157 |
$ |
- |
The
Company enters into purchase commitments for products and services in the
ordinary course of business. These purchases generally cover production
requirements for 60 to 90 days. We do not have any long-term commitments for
purchases.
20
Critical
Accounting Policies
In
response to the SEC’s financial reporting release, FR-60, “Cautionary
Advice Regarding Disclosure About Critical Accounting
Policies,” we have
selected our critical accounting policies for purposes of explaining the
methodology used in the calculation in addition to any inherent uncertainties
pertaining to the possible effects on our financial condition. The critical
policies discussed below are our processes of recognizing the allowance
for obsolete and slow-moving inventory, the allowance for doubtful accounts,
income tax, and the reserve for warranties. These policies affect current assets
and operating results and are therefore critical in assessing our financial and
operating status. These policies involve certain assumptions that, if incorrect,
could create an adverse impact on our operations and financial
position.
The
Reserve for Obsolescence
Since the
amount of inventoriable cost that we will truly recoup through sales cannot be
known with exact certainty, we rely upon both past sales experience and future
sales forecasts. Inventory is considered obsolete if we have withdrawn those
products from the market or if we had no sales of the product for the past 12
months, and have no sales forecasted for the next 12 months. Accordingly, a
reserve in an amount equal to 100% of the average cost of such inventory is
recorded in order to reduce the carrying value to net realizable value.
The
Allowance for Doubtful Accounts
We
perform ongoing evaluations of our customers and adjust their credit ratings
accordingly. We continuously monitor collections and payments from our customers
and maintain an allowance for un-collectible amounts based on its historical
experience and any other issues it has identified. While such credit losses have
historically been within its expectations, we cannot guarantee this will
continue in the future.
21
Income
Taxes
We review
our deferred tax assets on a regular basis to evaluate their recoverability
based on projections of the turnaround timing of our deferred tax liabilities,
projections of future taxable income, and tax planning strategies that we might
employ to utilize such assets, including net operating loss carryforwards. Based
on the positive and negative evidence described in Financial Accounting
Standards Board (FASB) Statement No. 109, “Accounting
for Income Taxes” (SFAS
109), we establish a valuation allowance against the net deferred assets of a
taxing jurisdiction in which we operate unless it is “more likely than not” that
we will recover such assets through the above means. In the future, our
evaluation of the need for the valuation allowance will be significantly
influenced by our ability to achieve profitability and our ability to predict
and achieve future projections of taxable income.
The
Company operates in a number of different countries around the world. In 2003
the Company began to manufacture its products in Switzerland, where it has
received a permanent income tax rate commitment from the Swiss government as an
incentive to establish a manufacturing plant there. The Company does not provide
deferred tax assets on temporary differences scheduled to reverse after the
commitment period because all of its earnings are included in the current tax
provision. Approximately 60% of all finished goods shipments come from the Swiss
plant, with the balance coming from the Company’s manufacturing facilities
located in the United States.
Significant
judgment is required in determine our worldwide provision for income taxes. In
the ordinary course of global business, there are many transactions for which
the ultimate tax outcome is uncertain. We have appropriately reserved for our
tax uncertainties based on the criteria established by SFAS 5, “Accounting
for loss contingencies”. Some of
the uncertainties arise as a result of inter-company arrangements to share
revenue and costs. In such arrangements there are uncertainties about the amount
and manner of such sharing, which could ultimately result in changes once the
arrangements are reviewed by taxing authorities.
The
Reserve for Warranties
The
Company establishes a liability for included twelve-month warranties by the
creation of a warranty reserve, which is an estimate of the repair expenses
likely to be incurred for the remaining period of warranty measured in
installation-months in each major product group. Warranty reserve is reflected
in accrued liabilities in the accompanying consolidated balance sheets. The
warranty expense is estimated by determining the total repair expenses for each
product group in the period and determining a rate of repair expense per
installation month. The rate is multiplied by the number of machine-months of
warranty for each product group sold during the period to determine the
provision for warranty expenses for the period. The Company reevaluates its
exposure to warranty costs at the end of each period using the estimated expense
per installation month for each major product group, the number of machines
remaining under warranty and the remaining number of months each machine will be
under warranty. While such expenses have historically been within its
expectations, we cannot guarantee this will continue in the future.
22
Transactions with Related and Other
Parties
The
Company leases its headquarters in Lake Mary, Florida from Xenon Research, Inc.,
all of the issued and outstanding capital stock of which is owned by Simon Raab,
the Company's Chief Executive Officer, and Diana Raab, his spouse. The term of
the lease expires on February 28, 2006, and the Company has a
five-year renewal option. Base rent under the lease was $398,000 for 2004,
2003 and 2002. Base rent during renewal periods will reflect changes in the U.S.
Bureau of Labor Statistics Consumer Price Index for all Urban
Consumers.
In May
1998, the Company acquired CATS GmbH, a German company (CATS). On June 20, 2000
the Company and each of the former CATS shareholders entered into an Amended and
Restated Loan Agreement pursuant to which the Company granted loans to the
former CATS shareholders in the aggregate amount of $1.1 million (The Loans).
The Loans outstanding were for a term of three years, at an interest rate of
approximately 4.7%, and granted the borrowers an option to extend the term for
an additional three years. The loans were repaid to the Company in
2003.
The
Company engaged Cole & Partners, a mergers and acquisition and corporate
finance advisory service firm, to serve as the Company’s financial advisor in
connection with the Company’s acquisition in January 2002 of SMX. Stephen R.
Cole, one of the Company’s directors and member of the Audit Committee, is the
founding partner and president of Cole & Partners. The Company paid Cole
& Partners total fees of $450,000 for its services, of which the final
payment of $300,000 was paid in 2002. No fees were paid to Cole & Partners
in 2004 or 2003.
Foreign
Exchange Exposure
We
conduct a significant portion of our business outside the United States. At
present, approximately 50% of our revenues are invoiced, and a significant
portion of our operating expenses paid, in foreign currencies. Fluctuations in
exchange rates between the U.S. dollar and such foreign currencies may have a
material adverse effect on our business, results of operations and financial
condition, and could specifically result in foreign exchange gains and losses.
The impact of future exchange rate fluctuations on the results of our operations
cannot be accurately predicted. To the extent that the percentage of our
non-U.S. dollar revenues derived from international sales increases (or
decreases) in the future, our exposure to risks associated with fluctuations in
foreign exchange rates may increase (or decrease).
Inflation
The
Company believes that inflation has not had a material impact on its results of
operations in recent years and does not expect inflation to have a material
impact on its operations in 2005.
Impact
of Recently Issued Accounting Standards
In
January 2003, the FASB issued and subsequently revised in December of 2003, FIN
46, "Consolidation
of Variable Interest Entities" (FIN
46). This
interpretation of ARB No. 51, "Consolidated
Financial Statements,"
addresses consolidation by business enterprises of variable interest entities.
Under current practice, two enterprises generally have been included in
consolidated financial statements because one enterprise controls the other
through voting interests. FIN 46 defines the concept of "variable interests" and
requires existing unconsolidated variable interest entities to be consolidated
by their primary beneficiaries if the entities do not effectively disperse the
risks among the parties involved. FIN 46 applied immediately to variable
interest entities created after January 31, 2003, and to variable interest
entities in which an enterprise obtains an interest after that date. It applied
to the first fiscal year or interim period beginning after June 15, 2003, to
variable interest entities in which an enterprise holds a variable interest that
it acquired before February 1, 2003. FIN 46(R) deferred the effective date of
FIN 46 to the first reporting period ending after December 15, 2003. If it is
reasonably possible that an enterprise will consolidate or disclose information
about a variable interest entity when this interpretation becomes effective, the
enterprise shall disclose information about those entities in all financial
statements issued after January 31, 2003. FIN 46 may be applied prospectively
with a cumulative-effect adjustment as of the date on which it is first applied
or by restating previously issued financial statements for one or more years
with a cumulative-effect adjustment as of the beginning of the first year
restated. In light of current proposed changes to FIN 46, we are continuing our
assessment to determine whether we are party to any variable interest entities.
23
In May
2003, the FASB issued Statement of Financial Accounting Standards (SFAS) No.
150,“Accounting
for Certain Financial Instruments with Characteristics of both Liabilities and
Equity”. SFAS No.
150 establishes standards for how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. SFAS
No. 150 requires that an issuer classify a financial instrument that is within
its scope as a liability (or an asset in some circumstances). SFAS No. 150 was
effective at the beginning of the first interim period beginning after June 15,
2003. The adoption of SFAS No. 150 did not have a material impact on our
financial position or results of operations.
In
November 2004, the FASB issued SFAS No. 151, “Inventory
Costs, an Amendment of ARB No. 43, Chapter 4”. SFAS
No. 151 retains the general principle of ARB No. 43, Chapter 4, “Inventory
Pricing,” that
inventories are presumed to be stated at cost; however, it amends ARB No. 43 to
clarify that abnormal amounts of idle facilities, freight, handling costs and
spoilage should be recognized as current period expenses. Also, SFAS No. 151
requires fixed overhead costs be allocated to inventories based on normal
production capacity. The guidance in SAFS No. 151 is effective for inventory
costs incurred during fiscal years beginning after June 15, 2005. The Company
believes that implementing SFAS No. 151 will not have a material impact on its
financial position or results of operations.
In
December 2004, the FASB issued SFAS No. 123R, “Share-Based
Payment”. SFAS
No. 123R requires employee stock options and rights to purchase shares under
stock participation plans to be accounted for under the fair value method, and
eliminates the ability to account for these instruments under the intrinsic
value method prescribed by APB Opinion No. 25, as allowed under the original
provisions of SFAS No. 123. SFAS No. 123R requires the use of an option pricing
model for estimating fair value, which is amortized to expense over the service
periods. The requirements of SFAS No. 123R are effective for fiscal periods
beginning after June 15, 2005. If the Company had applied the provisions of SFAS
No. 123 to the financial statements for the period ending December 31, 2004, net
income would have been reduced by approximately $1.2 million using the
Black-Scholes option pricing model. We expect to incur expenses of approximately
$2 million in 2005 as calculated under the Black-Scholes method of SFAS
123, related to our expected adoption of SFAS No. 123(R) for the
expensing of stock options. We are investigating other valuation methods for
these expenses prior to our adoption of SFAS 123(R).
Cautionary
Statements
We
discuss expectations regarding our future performance and make other
forward-looking statements in our annual and quarterly reports, press releases
and other written and oral statements. These forward-looking statements are
based on currently available competitive, financial and economic data and our
operating plans. They are inherently uncertain, and investors must recognize
that events could turn out to be significantly different from our expectations.
The following discussion of risks and uncertainties which is not exclusive,
highlights some important factors to consider when evaluating our trends and
future results.
24
Our
customers' buying process for our products is highly decentralized, and
therefore, it typically requires significant time and expense for us to further
penetrate the potential market of a specific customer, which may delay our
ability to generate additional revenue.
Our
success will depend, in part, on our ability to further penetrate our customer
base. During 2004, 52.7% of our revenue was attributable to sales to our
existing customers, compared to 54.6% in 2003. If we are not able to continue to
penetrate our existing customer base, our sales growth will be impaired. Most of
our customers have a decentralized buying process for measurement devices. Thus,
we must spend significant time and resources to increase revenues from a
specific customer. For example, we may provide products to only one of our
customers manufacturing facilities or for a specific product line within a
manufacturing facility. We cannot be certain that we will be able to
maintain or increase the amount of sales to our existing customers.
Others
may develop products that make our products obsolete or less competitive.
The CAM2
market is emerging and could be characterized by rapid technological change.
Others may develop new or improved products, processes or technologies that may
make our products obsolete or less competitive. We cannot assure you that we
will be able to adapt to evolving markets and technologies or maintain our
technological advantage.
Our
success will depend, in part, on our ability to maintain our technological
advantage by developing new products and applications and enhancing our existing
products. Developing new products and applications and enhancing our existing
products can be complex and time-consuming and will require substantial
investment by us. Significant delays in new product releases or difficulties in
developing new products could adversely affect our revenues and results of
operations. Because our customers are concentrated in a few industries, a
reduction in sales to any one of these industries could cause a significant
decline in our revenues.
An
economic slowdown in manufacturing will affect our growth and profitability.
Approximately
75% of our sales are to manufacturers in the automotive, aerospace and heavy
equipment industries. We are dependent upon the continued growth, viability and
financial stability of our customers in these industries, which are highly
cyclical and dependent upon the general health of the economy and consumer
spending. The cyclical nature of these industries may exert significant
influence on our revenues and results of operations. In addition, the volume of
orders from our customers and the prices of our products may be adversely
impacted by decreases in capital spending by a significant portion of our
customers during recessionary periods. In addition, we generate significant
accounts receivable in connection with providing products and services to our
customers. If one or more of our significant customers were to become insolvent
or otherwise were unable to pay for the products provided by us, our operating
results and financial condition would be adversely affected.
The
potential size and growth of the CAM2 market could be less than we anticipate.
Because
the CAM2 market is emerging, the potential size and growth of the CAM2 market is
uncertain and difficult to quantify. If the CAM2 market does not continue to
expand or does not expand at least as quickly as we anticipate, we will not be
able to continue our sales growth, which will affect our
profitability.
25
Our
inability to protect our patents and proprietary rights in the United States and
foreign countries could adversely affect our revenues.
Our
success depends in large part on our ability to obtain and maintain patent and
other proprietary right protection for our processes and products in the United
States and other countries. We also rely upon trade secrets, technical know-how
and continuing inventions to maintain our competitive position. We seek to
protect our technology and trade secrets, in part, by confidentiality agreements
with our employees and contractors. Our employees may breach these agreements or
our trade secrets may otherwise become known or be independently discovered by
inventors. If we are unable to obtain or maintain protection of our patents,
trade secrets and other proprietary rights, we may not be able to prevent third
parties from using our proprietary rights.
Our
patent protection involves complex legal and technical questions. Our patents
may be challenged, narrowed, invalidated or circumvented. We may be able to
protect our proprietary rights from infringement by third parties only to the
extent that our proprietary processes and products are covered by valid and
enforceable patents or are effectively maintained as trade secrets. Furthermore,
others may independently develop similar or alternative technologies or design
around our patented technologies. Litigation or other proceedings to defend or
enforce our intellectual property rights could require us to spend significant
time and money and could otherwise adversely affect our business.
Claims
from others that we infringe their intellectual property rights may adversely
affect our operations.
From time
to time we receive notices from others claiming we infringe their intellectual
property rights. The number of these claims may grow. Responding to these claims
may require us to enter into royalty and licensing agreements on unfavorable
terms, require us to stop selling or to redesign affected products or require us
to pay damages. Any litigation or interference proceedings, regardless of their
outcome, may be costly and may require significant time and attention of our
management and technical personnel.
Our
operating results may fluctuate due to a number of factors, many of which are
beyond our control.
Our
annual and quarterly operating results have varied significantly in the past and
likely will vary significantly in the future as a result of:
· |
the
size and timing of customer orders, many of which are received towards the
end of the quarter; |
· |
sales
promotions and sales of demonstration
equipment; |
· |
geographic
expansion in the Asia/Pacific region and other
regions; |
· |
training
and ramp-up time for new sales people; |
· |
investments
in technologies and new products; |
· |
our
effective tax rate; |
· |
the
amount of time that it takes to fulfill orders and ship our products;
|
· |
the
length of our sales cycle to new customers and the time and expense
incurred in further penetrating our existing customer base;
|
26
· |
increases
in operating expenses for product development and new product marketing;
|
· |
costs
associated with new product introductions, such as assembly line start-up
costs and low introductory period production volumes;
|
· |
the
timing and market acceptance of new products and product enhancements;
|
· |
customer
order deferrals in anticipation of new products and product enhancements;
|
· |
our
success in expanding our sales and marketing programs;
|
· |
start-up
costs and ramp-up time associated with opening new sales offices outside
of the United States; |
· |
fluctuations
in revenue without proportionate adjustments in fixed costs;
|
· |
the
efficiencies achieved in managing inventories and fixed assets; and
|
· |
adverse
changes in the manufacturing industry and general economic conditions.
|
Any one
or a combination of these factors could adversely affect our annual and
quarterly operating results in the future.
The
CAM2 market is an emerging market and our growth depends on the ability of our
products to attain broad market acceptance.
The CAM2
market is in an early stage of adoption. The market for traditional fixed-base
CMMs, check fixtures, and other handheld measurement tools is mature. Part of
our strategy is to continue to displace these traditional measurement devices.
Displacing traditional measurement devices and achieving broad market acceptance
of our products requires significant effort to convince manufacturers to
reevaluate their historical measurement procedures and methodologies.
We market
four closely interdependent products (Faro Arm, Scan Arm, Faro Laser Tracker and
Faro Gage) and related software for use in measurement and inspection
applications. Substantially all our revenues are currently derived from sales of
these products and software and we plan to continue our business strategy of
focusing on the portable software-driven, 3-D measurement and inspection market.
Consequently, our financial performance will depend in large part on portable,
computer-based measurement and inspection products achieving broad market
acceptance. If our products cannot attain broad market acceptance, we will not
grow as anticipated and may be required to make increased
expenditures
on research and development for new applications or new products.
We
compete with manufacturers of portable measurement systems and traditional
measurement devices, many of which have more resources than us and may develop
products or technologies that will directly compete with us.
Our
portable measurement systems compete in the broad market for measurement devices
for manufacturing and industrial applications, which, in addition to portable
articulated arms and laser tracker products, consists of fixed-base CMMs, check
fixtures, and handheld measurement tools. The broad market for measurement
devices is highly competitive. In the Faro Gage product line, manufacturers of
handheld measurement tools and fixed-base CMMs include a significant number of
well-established companies that are substantially larger and possess
substantially greater financial, technical and marketing resources than we
possess. In the Faro Arm product line, we compete with Hexagon Metrology, who is
significantly larger than us. In the Faro Laser Tracker product line, we compete
primarily with Leica Geosystems, who is significantly larger than us. We will be
required to make continued investments in technology and product development to
maintain our technological advantage over our competition. We cannot assure you
that we will have sufficient resources to make additional investments in
technology and product development or that our product development efforts will
allow us to successfully compete as the industry evolves.
27
Our
competitors may develop products or technologies that directly compete with us.
For example, fixed-base CMM manufacturers are introducing CAD-based inspection
software in response to the trend toward CAD-based factory floor metrology. In
addition, some fixed-base CMM manufacturers are miniaturizing and increasing the
mobility of their conventional CMMs. These companies may continue to alter their
products and devote resources to the development and marketing of additional
products that compete with ours.
We
derive a substantial part of our revenues from our international operations,
which are subject to greater volatility and often require more management time
and expense to achieve profitability than our domestic operations.
Since
2000, we have derived approximately 50% of our sales from international
operations. We opened a manufacturing facility in Schaffhausen, Switzerland in
2003 and have regional sales offices in Germany, France, Spain, Italy, Japan,
China, India, South Korea and the United Kingdom. Should trade relations between
the United States and China deteriorate, our ability to transfer products
between China and other regions of the world, including the United States, Asia
and Europe could be significantly impaired and our results of operations would
suffer. In our experience, entry into new international markets requires
considerable management time as well as start-up expenses for market
development, hiring and establishing office facilities before any significant
revenues are generated. As a result, initial operations in a new market may
operate at low margins or may be unprofitable. Our international operations may
be subject to a number of risks including:
· |
difficulties
in staffing and managing foreign operations;
|
· |
political
and economic instability; |
· |
unexpected
changes in regulatory requirements and laws;
|
· |
longer
customer payment cycles and difficulty collecting accounts receivable;
|
· |
export
duties, import controls and trade barriers;
|
· |
governmental
restrictions on the transfer of funds to us from our operations outside
the United States; |
· |
burdens
of complying with a wide variety of foreign laws and labor practices;
and |
· |
fluctuations
in currency exchange rates, which could affect local payroll utility and
other expenses. |
28
Several
of the countries where we operate have emerging or developing economies, which
may be subject to greater currency volatility, negative growth, high inflation,
limited availability of foreign exchange and other risks. These factors may harm
our results of operations and any measures that we may implement to reduce the
effect of volatile currencies and other risks of our international operations
may not be effective. In addition, during 1997 and 1998 several Asian countries,
including Japan, experienced severe currency fluctuation and economic deflation.
If such situations reoccur or occur in other regions where we operate, it may
negatively impact our sales and our ability to collect payments from customers
in these regions.
We
rely to a large extent on the experience and management ability of our senior
executive officers.
Our
success will depend, in part, on the services of our founders, Simon Raab, our
Chief Executive Officer, and Gregory Fraser, our Executive Vice President,
Secretary and Treasurer, and Jay Freeland, our President and Chief Operating
Officer, who was hired in November 2004, and our Chief Financial Officer,
Barbara Smith, who was hired in February 2005. The loss or interruption of the
continued full-time services of these executives could have a material adverse
effect on us. We do not have employment agreements with these executives.
We
may not be able to identify, consummate or achieve expected benefits from
acquisitions.
We have
completed two significant acquisitions since our initial public offering in
1997. We intend to pursue access to additional technologies, complementary
product lines and sales channels through selective acquisitions and strategic
investments. We may not be able to identify and successfully negotiate suitable
acquisitions, obtain financing for future acquisitions on satisfactory terms or
otherwise complete acquisitions in the future. In the past we have used our
stock as consideration for acquisitions. Our common stock may not remain at a
price at which it can be used as consideration for acquisitions without diluting
our existing shareholders, and potential acquisition candidates may not view our
stock attractively.
Realization
of the benefits of acquisitions often requires integration of some or all of the
acquired companies' sales and marketing, distribution, manufacturing,
engineering, finance and administrative organizations. The integration of
acquisitions demands substantial attention from senior management and the
management of the acquired companies. Any acquisition may be subject to a
variety of risks and uncertainties including:
· |
the
inability to assimilate effectively the operations, products, technologies
and personnel of the acquired companies (some of which may be located in
diverse geographic regions); |
· |
the
inability to maintain uniform standards, controls, procedures and
policies; |
· |
the
need or obligation to divest portions of the acquired companies; and
|
· |
the
potential impairment of relationships with customers.
|
We cannot
assure you that we will be able to integrate successfully any acquisitions, that
any acquired companies will operate profitably or that we will realize the
expected benefits from any acquisition.
We
may face difficulties managing growth.
Our
growth has placed significant demands on our management and operations and
financial resources. If our business continues to grow rapidly in the future, we
expect it to result in:
29
· |
increased
responsibility for existing and new management personnel; and
|
· |
incremental
strain on our operations and financial and management systems.
|
Our
success under such conditions will depend to a significant extent on the ability
of our executive officers and other members of senior management to operate
effectively both independently and as a group. If we are not able to manage
future growth, our business, financial condition and operating results may be
harmed.
Our
dependence on suppliers for materials could impair our ability to manufacture
our products.
Outside
vendors provide key components used by us in the manufacture of our products.
Although we believe that alternative sources for these components are available,
any supply interruption in a limited source component would harm our ability to
manufacture our products until a new source of supply is identified. In
addition, an uncorrected defect or supplier's variation in a component, either
known or unknown to us, or incompatible with our manufacturing processes, could
harm our ability to manufacture our products. We may not be able to find a
sufficient alternative supplier in a reasonable period, or on commercially
reasonable terms, if at all. If we fail to obtain a supplier for the manufacture
of components of our potential products, we may experience delays or
interruptions in our operations, which would adversely affect our results of
operations and financial condition.
We
may experience volatility in our stock price.
The price
of our common stock has been, and may continue to be, highly volatile in
response to various factors, many of which are beyond our control, including:
· |
developments
in the industries in which we operate; |
· |
actual
or anticipated variations in quarterly or annual operating results;
|
· |
speculation
in the press or investment community; and |
· |
announcements
of technological innovations or new products by us or our competitors.
|
Our
common stock's market price may also be affected by our inability to meet
analyst and investor expectations and failure to achieve projected financial
results, including those set forth in this prospectus. Any failure to meet such
expectations or projected financial results, even if minor, could cause the
market price of our common stock to decline. Volatility in our stock price may
result in your inability to sell your shares at or above the price at which you
purchased them.
In
addition, stock markets have generally experienced a high level of price and
volume volatility, and the market prices of equity securities of many companies
have experienced wide price fluctuations not necessarily related to the
operating performance of such companies. These broad market fluctuations may
adversely affect our common stock's market price. In the past, securities class
action lawsuits frequently have been instituted against such companies following
periods of volatility in the market price of such companies' securities. If any
such litigation is instigated against us, it could result in substantial costs
and a diversion of management's attention and resources, which could have a
material adverse effect on our business, results of operations and financial
condition.
Our
executive officers and directors control a significant percentage of our common
stock and these shareholders may take actions that are adverse to your
interests.
30
Our two
co-founders, Simon Raab and Gregory Fraser, beneficially own approximately
19.24% of our common stock. As a result, these shareholders, acting together,
can significantly influence all matters requiring shareholder approval,
including the election and removal of directors and approval of significant
corporate transactions such as mergers, consolidations and sales of assets. They
also could dictate the management of our business and affairs. This
concentration of ownership could have the effect of delaying, deferring or
preventing a change in control or impeding a merger or consolidation, takeover
or other business combination, which could cause the market price of our common
stock to fall or prevent you from receiving a premium in such a transaction.
Anti-takeover
provisions in our articles of incorporation, our bylaws and provisions of
Florida law could delay or prevent a change of control that you may favor.
Our
articles of incorporation, our bylaws and provisions of Florida law could make
it more difficult for a third party to acquire us, even if doing so would be
beneficial to you. These provisions could discourage potential takeover attempts
and could adversely affect the market price of our shares. Because of these
provisions, you might not be able to receive a premium on your investment. These
provisions include:
· |
a
limitation on shareholders' ability to call a special meeting of our
shareholders; |
· |
advance
notice requirements to nominate directors for election to our board of
directors or to propose matters that can be acted on by shareholders at
shareholder meetings; |
· |
our
classified board of directors, which means that approximately one-third of
our directors are elected each year; and |
· |
the
authority of the board of directors to issue, without shareholder
approval, preferred stock with such terms as the board of directors may
determine. |
The
provisions described above could delay or make more difficult transactions
involving a change in control of us, or our management.
Item
7A.
Quantitative and Qualitative Disclosures about Market
Risk.
Foreign
Exchange Exposure
The
Company conducts a significant portion of its business outside the United
States. At present, a slight majority of the Company’s revenues are invoiced,
and a significant portion of its operating expenses paid, in foreign currencies.
Fluctuations in exchange rates between the U.S. dollar and such foreign
currencies may have a material adverse effect on the Company’s business, results
of operations and financial condition, and could specifically result in foreign
exchange gains and losses. The impact of future exchange rate fluctuations on
the results of the Company’s operations cannot be accurately predicted. To the
extent that the percentage of the Company’s non-U.S. dollar revenues derived
from international sales increases in the future, the Company’s exposure to
risks associated with fluctuations in foreign exchange rates will increase
further.
Inflation
The
Company believes that inflation has not had a material impact on its results of
operations in recent years and does not expect inflation to have a material
impact on its operations in 2004.
31
Item 8.
Financial Statements and Supplementary Data.
Page | ||
Reports of Independent Registered Public Accounting Firms |
33 to 34 | |
Consolidated Balance Sheets as of December 31, 2004 and 2003 |
35 | |
Consolidated Statements of Operations for the Years Ended December 31, 2004, 2003 and 2002 |
36 | |
Consolidated Statements of Shareholders’ Equity for the Years Ended December 31, 2004, 2003 and 2002 |
37 | |
Consolidated Statements of Cash Flows for the Years Ended December 31, 2004, 2003 and 2002 |
38 | |
Notes to the Consolidated Financial Statements |
39 to 55 |
32
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the Board of Directors and Shareholders of FARO Technologies, Inc.:
We have
audited the accompanying consolidated balance sheet of FARO Technologies, Inc.
(a Florida Corporation) and subsidiaries (collectively, the “Company”) as of
December 31, 2004, and the related consolidated statements of operations,
shareholders’ equity and cash flows for the year then ended. These financial
statements are the responsibility of the Company’s management. Our
responsibility is to express an opinion on these financial statements based on
our audit.
We
conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our
opinion, the consolidated financial statements referred to above present fairly,
in all material respects, the financial position of FARO Technologies, Inc. and
subsidiaries as of December 31, 2004, and the results of their operations and
their cash flows for the year then ended in conformity with accounting
principles generally accepted in the United States of America.
We also have audited, in accordance with the
standards of the Public Company Accounting Oversight Board (United States), the
effectiveness of FARO Technologies, Inc.'s internal control over financial
reporting as of December 31, 2004, based on criteria established in Internal
Control - Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) and our report dated Mach 14,
2005 expressed an unqualified opinion.
/s/ GRANT THORNTON LLP | |||
Orlando, Florida | |||
March 14, 2005 |
33
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors and Shareholders of FARO Technologies, Inc.:
We have
audited the accompanying consolidated balance sheet of FARO Technologies, Inc.
and subsidiaries as of December 31, 2003, and the related consolidated
statements of operations, shareholders' equity, and cash flows for each of the
two years in the period ended December 31, 2003. These financial statements are
the responsibility of the Company's management. Our responsibility is to express
an opinion on these financial statements based on our audit.
We
conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our
opinion, the financial statements referred to above present fairly, in all
material respects, the consolidated financial position of FARO Technologies,
Inc. and subsidiaries at December 31, 2003, and the consolidated results of
their operations and their cash flows for each of the two years in the period
ended December 31, 2003, in conformity with U.S. generally accepted accounting
principles.
As
described in Note 7 to the financial statements, the Company adopted Statement
of Financial Accounting Standards No. 142 “Goodwill and Other Intangible
Assets”, effective January 1, 2002.
/s/ ERNST & YOUNG LLP | |||
Orlando, Florida | |||
February 20, 2004 |
34
FARO
TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
|
December
31, |
December
31, |
||||||
|
|
|
2004 |
|
|
2003 |
||
ASSETS |
||||||||
Current Assets: | ||||||||
Cash
and cash equivalents |
$ |
16,357,235 |
$ |
17,424,901 |
||||
Short-term
investments |
22,485,000
|
16,037,208
|
||||||
Accounts
receivable, net of allowance for doubtful accounts of $338,740 and
$254,915, respectively |
22,484,008
|
16,312,978
|
||||||
Inventories |
16,377,770
|
12,270,527
|
||||||
Deferred
tax asset, net |
744,383
|
564,841
|
||||||
Prepaid
expenses and other current assets |
2,538,497
|
1,465,690
|
||||||
Total
current assets |
80,986,893
|
64,076,145
|
||||||
Property
and Equipment: |
||||||||
Machinery
and equipment |
4,351,642
|
5,612,391
|
||||||
Furniture
and fixtures |
2,393,855
|
2,552,766
|
||||||
Leasehold
improvements |
910,566
|
626,858
|
||||||
Property
and equipment at cost |
7,656,063
|
8,792,015
|
||||||
Less:
accumulated depreciation and amortization |
(3,641,237 |
) |
(6,038,658 |
) | ||||
Property
and equipment, net |
4,014,826
|
2,753,357
|
||||||
Goodwill |
8,076,590
|
8,001,340
|
||||||
Intangible
assets |
3,567,528
|
3,438,035
|
||||||
Service
Inventory |
4,159,087
|
2,501,265
|
||||||
Deferred
tax asset, net |
4,273,437
|
1,143,746
|
||||||
Total
Assets |
$ |
105,078,361 |
$ |
81,913,888 |
||||
LIABILITIES
AND SHAREHOLDERS' EQUITY |
||||||||
Current
Liabilities: |
||||||||
Accounts
payable |
$ |
4,735,653 |
$ |
4,713,512 |
||||
Accrued
liabilities |
7,251,908
|
4,776,778
|
||||||
Income
taxes payable |
104,373
|
605,456
|
||||||
Current
portion of unearned service revenues |
2,663,484
|
2,206,167
|
||||||
Customer
deposits |
440,619
|
363,346
|
||||||
Current
portion of obligations under capital leases |
103,713
|
42,584
|
||||||
Total
current liabilities |
15,299,750
|
12,707,843
|
||||||
Unearned
service revenues - less current portion |
474,353
|
220,296
|
||||||
Obligations
under capital leases - less current portion |
145,697
|
64,650
|
||||||
Total
Liabilities |
15,919,800
|
12,992,789
|
||||||
Commitments
and Contingencies - See Note 16 |
||||||||
Shareholders'
Equity: |
||||||||
Common
stock - par value $.001, 50,000,000 shares authorized; 14,004,092 and
13,518,998 issued; 13,964,092 and 13,478,998 outstanding,
respectively |
14,004
|
13,519
|
||||||
Additional
paid-in-capital |
78,282,150
|
75,133,219
|
||||||
Deferred
compensation |
505,213
|
(226,954 |
) | |||||
Retained
earnings (accumulated deficit) |
9,076,945
|
(5,853,929 |
) | |||||
Accumulated
other comprehensive income |
1,430,874
|
5,869
|
||||||
Common
stock in treasury, at cost - 40,000 shares |
(150,625 |
) |
(150,625 |
) | ||||
Total
shareholders' equity |
89,158,561
|
68,921,099
|
||||||
Total
Liabilities and Shareholders' Equity |
$ |
105,078,361 |
$ |
81,913,888 |
The
accompanying notes are an integral part of these consolidated financial
statements.
35
FARO
TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
Years
ended December 31, |
|||||||||
2004 |
|
|
2003 |
|
|
2002 |
| |||
SALES |
$ |
97,019,875 |
$ |
71,785,980 |
$ |
46,246,372 |
||||
COST
OF SALES (exclusive of depreciation and amortization, shown separately
below) |
37,023,704
|
29,520,249
|
21,109,609
|
|||||||
Gross
profit |
59,996,171
|
42,265,731
|
25,136,763
|
|||||||
OPERATING
EXPENSES: |
||||||||||
Selling
|
25,886,482
|
18,341,409
|
13,891,917
|
|||||||
General
and administrative |
11,745,313
|
9,834,690
|
7,882,864
|
|||||||
Depreciation
and amortization |
2,339,496
|
2,119,030
|
2,267,763
|
|||||||
Research
and development |
5,441,048
|
4,530,467
|
4,033,462
|
|||||||
Total
operating expenses |
45,412,339
|
34,825,596
|
28,076,006
|
|||||||
INCOME
(LOSS) FROM OPERATIONS |
14,583,832
|
7,440,135
|
(2,939,243 |
) | ||||||
OTHER
INCOME (EXPENSE) |
||||||||||
Interest
income |
355,682
|
81,680
|
561,112
|
|||||||
Other
income, net |
361,719
|
1,959,806
|
601,336
|
|||||||
Interest
expense |
(12,068 |
) |
(46,351 |
) |
(28,036 |
) | ||||
INCOME
(LOSS) BEFORE INCOME TAX |
15,289,165
|
9,435,270
|
(1,804,831 |
) | ||||||
INCOME
TAX EXPENSE |
358,291
|
1,157,530
|
210,740
|
|||||||
NET
INCOME (LOSS) |
$ |
14,930,874 |
$ |
8,277,740 |
$ |
(2,015,571 |
) | |||
NET
INCOME (LOSS) PER SHARE - BASIC |
$ |
1.08 |
$ |
0.68 |
$ |
(0.17 |
) | |||
NET
INCOME (LOSS) PER SHARE - DILUTED |
$ |
1.06 |
$ |
0.64 |
$ |
(0.17 |
) | |||
Weighted
average shares - Basic |
13,833,590
|
12,181,221
|
11,853,732
|
|||||||
Weighted
average shares - Diluted |
14,023,159
|
12,845,992
|
11,853,732
|
|||||||
The
accompanying notes are an integral part of these consolidated financial
statements.
36
FARO
TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF SHAREHOLDERS’ EQUITY
Retained |
Accumulated |
||||||||||||||||||||||||
|
Additional |
Earnings |
Other |
Common |
|||||||||||||||||||||
|
|
|
Common
Stock |
|
Paid-in |
|
Deferred |
|
(Accumulated |
|
Comprehensive |
|
Stock
in |
|
|
| |||||||||
|
|
|
Shares |
|
|
Amounts |
|
|
Capital |
|
|
Compensation |
|
|
Deficit) |
|
|
(Loss)
Income |
|
|
Treasury |
|
|
Total |
|
BALANCE
DECEMBER 31, 2001 |
11,075,252
|
$ |
11,075 |
$ |
47,704,087 |
$ |
(109,000 |
) |
$ |
(12,116,098 |
) |
$ |
(3,002,978 |
) |
$ |
(150,625 |
) |
$ |
32,336,461 |
||||||
Net
loss |
(2,015,571 |
) |
(2,015,571 |
) | |||||||||||||||||||||
Currency
translation adjustment |
1,209,209
|
1,209,209
|
|||||||||||||||||||||||
Comprehensive
loss |
(806,362 |
) | |||||||||||||||||||||||
Options
subject to variable accounting |
(84,706 |
) |
84,706
|
-
|
|||||||||||||||||||||
Amortization
of unearned compensation |
9,526
|
9,526
|
|||||||||||||||||||||||
Issuance
of common stock in connection |
|||||||||||||||||||||||||
with
the acquisition of SMX |
850,000
|
850
|
1,826,650
|
1,827,500
|
|||||||||||||||||||||
Issuance
of common stock |
6,474
|
7
|
16,517
|
16,524
|
|||||||||||||||||||||
BALANCE
DECEMBER 31, 2002 |
11,931,726
|
$ |
11,932 |
$ |
49,462,548 |
$ |
(14,768 |
) |
$ |
(14,131,669 |
) |
$ |
(1,793,769 |
) |
$ |
(150,625 |
) |
$ |
33,383,649 |
||||||
Net
income |
8,277,740
|
8,277,740
|
|||||||||||||||||||||||
Currency
translation adjustment |
1,799,638
|
1,799,638
|
|||||||||||||||||||||||
Comprehensive
income |
10,077,378
|
||||||||||||||||||||||||
Options
subject to variable accounting |
930,710
|
(930,710 |
) |
-
|
|||||||||||||||||||||
Amortization
of unearned compensation |
718,524
|
718,524
|
|||||||||||||||||||||||
Stock
options exercised |
528,839
|
529
|
1,300,509
|
1,301,038
|
|||||||||||||||||||||
Settlement
of SMX arbitration |
(99,567 |
) |
(100 |
) |
(1,155,873 |
) |
(1,155,973 |
) | |||||||||||||||||
Tax
benefit from employee stock option exercises |
1,419,678
|
1,419,678
|
|||||||||||||||||||||||
Issuance
of common stock, net of expenses |
1,158,000
|
1,158
|
23,175,647
|
23,176,805
|
|||||||||||||||||||||
BALANCE
DECEMBER 31, 2003 |
13,518,998
|
$ |
13,519 |
$ |
75,133,219 |
$ |
(226,954 |
) |
$ |
(5,853,929 |
) |
$ |
5,869 |
$ |
(150,625 |
) |
$ |
68,921,099 |
|||||||
Net
income |
|
14,930,874 |
14,930,874
|
||||||||||||||||||||||
Currency
translation adjustment |
|
1,425,005 |
1,425,005
|
||||||||||||||||||||||
Comprehensive
income |
16,355,879
|
||||||||||||||||||||||||
Options
subject to variable accounting |
|
(455,139 |
) |
|
455,139 |
-
|
|||||||||||||||||||
Amortization
of unearned compensation |
|
277,028 |
277,028
|
||||||||||||||||||||||
Stock
options exercised |
485,512
|
486
|
|
1,171,293 |
1,171,779
|
||||||||||||||||||||
Tax
benefit from employee stock option exercises |
|
2,433,673 |
2,433,673
|
||||||||||||||||||||||
Cancellation
of SMX shares |
(418 |
) |
(1 |
) |
|
(896 |
) |
(897 |
) | ||||||||||||||||
BALANCE
DECEMBER 31, 2004 |
14,004,092
|
$ |
14,004 |
$ |
78,282,150 |
$ |
505,213 |
$ |
9,076,945 |
$ |
1,430,874 |
$ |
(150,625 |
) |
$ |
89,158,561 |
The
accompanying notes are an integral part of these consolidated financial
statements.
37
FARO
TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
Years
ended December 31, |
|||||||||||
2004 |
|
|
2003 |
|
|
2002 |
||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||||
Net income |
$ |
14,930,874 |
$ |
8,277,740 |
$ |
(2,015,571 |
) | |||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||||||
Depreciation
and amortization |
2,339,496
|
2,119,030
|
2,267,763
|
|||||||||
Settlement
of SMX arbitration received in stock |
-
|
(1,155,973 |
) |
-
|
||||||||
Provision
for bad debts |
154,394
|
140,249
|
582,463
|
|||||||||
Foreign
currency gains |
-
|
-
|
(184,027 |
) | ||||||||
Income
tax benefit from exercise of stock options |
2,433,673
|
1,419,678
|
-
|
|||||||||
Deferred
income tax (benefit) expense |
(3,308,890 |
) |
(1,708,587 |
) |
76,418
|
|||||||
Employee
stock option expense |
277,028
|
718,524
|
9,526
|
|||||||||
Change in operating assets and liabilities: | ||||||||||||
Decrease (increase) in: | ||||||||||||
Accounts
receivable |
(5,474,260 |
) |
(898,460 |
) |
(2,514,764 |
) | ||||||
Income
taxes refundable |
-
|
-
|
545,118
|
|||||||||
Inventories
|
(5,353,821 |
) |
(4,996,032 |
) |
(1,989,635 |
) | ||||||
Prepaid
expenses and other current assets |
(1,019,286 |
) |
(228,618 |
) |
468,205
|
|||||||
Increase (decrease) in: | ||||||||||||
Accounts
payable and accrued liabilities |
2,138,013
|
961,070
|
(1,805,060 |
) | ||||||||
Income
taxes payable |
(501,973 |
) |
(320,730 |
) |
106,953
|
|||||||
Customer
deposits |
68,746
|
244,585
|
(947,999 |
) | ||||||||
Unearned
service revenues |
610,711
|
102,359
|
404,530
|
|||||||||
Net
cash provided by (used in) operating activities |
7,294,705
|
4,674,835
|
(4,996,080 |
) | ||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||||
Acquisition
of SMX |
-
|
-
|
(3,028,615 |
) | ||||||||
Purchases
of property and equipment |
(2,451,051 |
) |
(1,429,809 |
) |
(1,287,317 |
) | ||||||
Payments
for intangible assets |
(1,003,631 |
) |
(867,892 |
) |
(810,895 |
) | ||||||
Proceeds
from repayment of notes receivable |
-
|
1,240,210
|
-
|
|||||||||
Purchases
of short-term investments |
(30,390,000 |
) |
(15,847,468 |
) |
-
|
|||||||
Proceeds
from short-term investments |
23,942,208
|
1,675,275
|
5,009,223
|
|||||||||
Net
cash used in investing activities |
(9,902,474 |
) |
(15,229,684 |
) |
(117,604 |
) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||||
Borrowings
under line of credit |
-
|
-
|
1,459,647
|
|||||||||
Payments
on line of credit and capital leases |
(38,259 |
) |
(1,459,205 |
) |
(30,889 |
) | ||||||
Proceeds
from issuance of stock, net |
1,170,882
|
24,477,843
|
16,524
|
|||||||||
Net
cash provided by financing activities |
1,132,623
|
23,018,638
|
1,445,282
|
|||||||||
EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS |
407,480
|
937,498
|
453,452
|
|||||||||
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS |
(1,067,666 |
) |
13,401,287
|
(3,214,950 |
) | |||||||
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD |
17,424,901
|
4,023,614
|
7,238,564
|
|||||||||
CASH AND CASH EQUIVALENTS, END OF PERIOD | $ |
16,357,235 |
$ |
17,424,901 |
$ |
4,023,614 |
The
accompanying notes are an integral part of these consolidated financial
statements.
38
FARO
TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS
ENDED DECEMBER 31, 2004, 2003 and 2002
1. SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
Description
of Business—FARO
Technologies, Inc. and subsidiaries (collectively the “Company”) develop,
manufacture, market and support Computer Aided Design (CAD)-based quality
assurance products and CAD-based inspection and statistical process control
software. Its principal products include the Faro Arm and Faro Gage, both
articulated electromechanical measuring devices, and the Faro Laser Tracker, a
multi-axis laser based measuring device. Markets for the Company’s products
include automobile, aerospace and heavy equipment manufacturers. The Company
sells the vast majority of its products though a direct sales force located in
many of the world’s largest industrialized countries.
Principles
of Consolidation—The
consolidated financial statements of the Company include the accounts of FARO
Technologies, Inc. and all its subsidiaries. All significant intercompany
transactions and balances have been eliminated. The financial statements of the
foreign subsidiaries are translated into U.S. dollars using exchange rates in
effect at period-end for assets and liabilities and average exchange rates
during each reporting period for results of operations. Adjustments resulting
from translation of financial statements are reflected as a separate component
of accumulated other comprehensive income.
Revenue
Recognition, Product Warranty and Extended Maintenance
Contracts—Revenue
related to the Company’s measurement systems (integrated combinations of a
measurement device, a computer and software loaded on the computer and the
measurement device) is recognized upon shipment as the Company considers the
earnings process substantially complete as of the shipping date. The Company
warrants its products against defects in design, materials and workmanship for
one year. A provision for estimated future costs relating to warranty expenses
is recorded when products are shipped. Also included in the one year warranty is
a right to software upgrades. The Company believes that it has
appropriately recognized the revenue related to this upgrade right under the
provisions of SOP 97-2. Beginning in 2005, the software upgrade rights are no
longer included in the one year warranty and must be purchased separately. The
Company separately sells one and three year extended warranties. Extended
warranty revenues are recognized in proportion to maintenance costs projected to
be incurred. Costs relating to extended maintenance plans are recognized as
incurred. Revenue from sales of software only is recognized when no further
significant production, modification or customization of the software is
required and when the following criteria are met: persuasive evidence of a sales
agreement exists, delivery has occurred, and the sales price is fixed or
determinable and deemed collectible. Revenues resulting from sales of
comprehensive support, training and technology consulting services are
recognized as such services are performed and are deferred when billed in
advance of the performance of services. Revenue from the licensing agreements
for the use of its technology for medical applications is generally recognized
as licensees use the technology. Amounts representing royalties for the current
year and not received as of year-end, are estimated as due (based on historical
data) and recognized in the current year.
Cash
and Cash Equivalents—The
Company considers cash on hand and amounts on deposit with financial
institutions which have maturities of three months or less when purchased to be
cash and cash equivalents. The Company had deposits with foreign banks totaling
$14,043,782 and $7,632,836 as of December 31, 2004 and 2003, respectively.
Short-term
investments—Short-term
investments ordinarily consist of short-term debt securities acquired with cash
not immediately needed in operations, and are held at fair value.
Management
determines the appropriate classification of its short term investments at the
time of the purchase and reevaluates such determinations at each balance sheet
date. The Company’s short-term investments are diversified among high credit
quality securities in accordance with the Company’s investment policy.
39
Accounts
receivable and related allowance for doubtful accounts—Credit is
extended to customers based on an evaluation of a customer’s financial condition
and, generally, collateral is not required. Accounts receivable are generally
due within 30-90 days and are stated at amounts due from customers net of an
allowance for doubtful accounts. Accounts outstanding longer than the
contractual payment terms are considered past due. The Company makes judgments
as to the collectibility of accounts receivable based on historical trends and
future expectations. Management estimates an allowance for doubtful accounts
which adjusts gross trade accounts receivable to its net realizable value. To
determine the allowance for sales returns, management uses historical trends to
estimate future period product returns. The allowance for doubtful accounts is
based on an analysis of all receivables for possible impairment issues, and
historical write-off percentages. The Company writes-off accounts receivable
when they become uncollectible, and payments subsequently received on such
receivables are credited to the allowance for doubtful accounts. The Company
does not generally charge interest on past due receivables.
Inventories—Inventories
are stated at the lower of average cost or net realizable value. Shipping and
handling costs are classified as a component of cost of sales in the
consolidated statements of operations. Sales demonstration inventory is
comprised of measuring devices utilized by sales representatives to present the
Company’s products to customers. These products remain in sales demonstration
inventory for six to twelve months and are subsequently sold at prices that
produce slightly reduced gross margins. Service inventory is comprised of
inventory that is not expected to be sold within twelve months, such as training
and loaned equipment.
Property
and Equipment—Property
and equipment purchases exceeding $1,000 are capitalized and recorded at cost.
Depreciation is computed using the straight-line method over the estimated
useful lives of the various classes of assets as follows:
Machinery
and equipment |
|
2
to 5 years |
Furniture
and fixtures |
|
3
to 10 years |
Leasehold
improvements are amortized on the straight-line basis over the lesser of the
life of the asset or the term of the lease, not to exceed 7 years.
Depreciation
expense was $1,453,103, $1,132,225 and $1,111,095 in 2004, 2003 and 2002,
respectively. Accelerated methods of depreciation are used for income tax
purposes in contrast to book purposes, and as a result, appropriate provisions
are made for the related deferred income taxes.
Goodwill
and Intangibles—
Goodwill represents the excess cost of a business acquisition over the fair
value of the net assets acquired. In accordance with Statement of Financial
Accounting Standards (SFAS) No. 142, “Goodwill
and Other Intangible Assets,”
indefinite-life identifiable intangible assets and goodwill are not amortized.
The Company periodically reviews its identifiable intangible assets and
goodwill, considering factors such as projected cash flows and revenue and
earnings multiples, to determine whether the value of the assets are impaired
and the amortization periods are appropriate. If an asset is impaired, the
difference between the value of the asset reflected on the financial statements
and its current fair value is recognized as an expense in the period in which
the impairment occurs.
Other
acquired intangibles principally include core technology, existing product
technology and customer relationships that arose in connection with the
acquisition of CATS GmbH, a German company (CATS). Other acquired intangibles
are recorded at fair value at the date of acquisition and are amortized over
their estimated useful lives of primarily 3 to 5 years.
40
Patents
are recorded at cost. Amortization is computed using the straight-line method
over the lives of the patents, which is 17 years.
Research
and Development—Research
and development costs incurred in the discovery of new knowledge and the
resulting translation of this new knowledge into plans and designs for new
products, prior to the attainment of the related products’ technological
feasibility, are recorded as expenses in the period incurred.
Income
Taxes—Deferred
tax assets and liabilities reflect the future income tax effects of temporary
differences between the consolidated financial statement carrying amounts of
existing assets and liabilities and their respective tax bases and are measured
using enacted tax rates that apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. Temporary items
result primarily from loss carryforwards, tax credits, depreciation,
amortization, and deferred revenue items. Deferred tax assets are reduced by a
valuation allowance when, in the opinion of management, it is more likely than
not that some portion or all of the deferred tax assets will not be realized.
Fair
Value of Financial Instruments—The
Company’s financial instruments include cash and cash equivalents, short-term
investments and accounts receivable. The carrying amounts of such financial
instruments approximate their fair value due to the short-term nature of these
instruments.
Earnings
Per Share—Basic
earnings per share (EPS) is computed by dividing earnings available to common
shareholders by the weighted-average number of common shares outstanding for the
period. Diluted EPS includes the effect of all dilutive stock options and equity
instruments. A reconciliation of the number of common shares used in calculation
of basic and diluted EPS is presented in Note 18.
Concentration
of Credit Risk—Financial
instruments which potentially expose the Company to concentrations of credit
risk consist principally of short-term investments and operating demand deposit
accounts. The Company’s policy is to place its operating demand deposit accounts
with high credit quality financial institutions.
Stock-Based
Compensation—In
December 2002, the Financial Accounting Standards Board (“FASB”) issued SFAS No.
148, “Accounting
for Stock-Based Compensation-Transition and Disclosure”. SFAS No.
148 provides alternative methods of transition for a voluntary change to the
fair value based method of accounting for stock-based compensation. In addition,
SFAS No. 148 amends the disclosure requirements of SFAS No. 123, “Accounting
for Stock-Based Compensation,” to
require prominent disclosures in both annual and interim financial statements
about the method of accounting for stock-based compensation and the effect of
the method used on reported results. SFAS No. 148 is effective for financial
statements for fiscal years ending after December 15, 2002 and for interim
periods beginning after December 15, 2002. The annual disclosure requirements of
SFAS No. 148 were adopted by the Company on January 1, 2003.
In
accordance with SFAS No. 123, the Company has elected to continue to account for
its employee stock compensation plans using the intrinsic value based method
with pro-forma disclosures of net earnings and earnings per share, as if the
fair value based method of accounting defined in SFAS No. 123 had been applied.
Under the intrinsic value based method, compensation cost is measured by the
excess, if any, of the quoted market price of the stock at the grant date over
the amount an employee must pay to acquire the stock. Under the fair value based
method, compensation cost is measured at the grant date based on the fair value
of the award and is recognized over the service period, which is usually the
vesting period.
41
Had
compensation cost for the Company’s stock-based compensation plans been
determined consistent with SFAS No. 123, the Company’s net income (loss) and
earnings (loss) per share would have been as follows:
|
Years
ended December 31, |
|||||||||
|
2004 |
|
|
2003 |
|
|
2002 |
|||
Net
income (loss), as reported |
$ |
14,930,874 |
$ |
8,277,740 |
$ |
(2,015,571 |
) | |||
Add:
Stock-based employee compensation expense included in reported net income,
net of related tax effects* |
172,866
|
448,143
|
9,526
|
|||||||
Deduct:
Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects |
(1,358,055 |
) |
(317,000 |
) |
(386,801 |
) | ||||
Pro
forma net income (loss) |
$ |
13,745,685 |
$ |
8,408,883 |
$ |
(2,392,846 |
) | |||
Earnings
(loss) per share: |
||||||||||
Basic
- as reported |
$ |
1.08 |
$ |
0.68 |
$ |
(0.17 |
) | |||
Basic
- pro forma |
$ |
0.99 |
$ |
0.69 |
$ |
(0.21 |
) | |||
Diluted
- as reported |
$ |
1.06 |
$ |
0.64 |
$ |
(0.17 |
) | |||
Diluted
- pro forma |
$ |
0.98 |
$ |
0.65 |
$ |
(0.21 |
) | |||
*The
years ended 2004, 2003, and 2002 assume a tax rate of 37.6%, 37.6%, and
0%, respectively. |
The
Company used the Black-Scholes option-pricing model to determine the fair value
of grants made. The following assumptions were applied in determining the pro
forma compensation cost:
2004 |
|
2003 |
2002 |
|||||||
Risk-free
interest rate |
2.54%
to 3.82 |
% |
2.48%
to 3.43 |
% |
2.51%
to 5.13 |
% | ||||
Expected
dividend yield |
0 |
% |
0 |
% |
0 |
% | ||||
Expected
option life |
5
years |
3 -
10 years |
3 -
10 years |
|||||||
Stock
price volatility |
80.54 |
% |
74.20 |
% |
62.30 |
% |
In April
2000, the FASB issued FIN 44, “Accounting
for Certain Transactions Involving Stock Compensation, an Interpretation of APB
Opinion No. 25.” FIN 44
clarifies and modifies APB Opinion No. 25, “Accounting
for Stock Issued to Employees.”
Long-Lived
Assets—Effective
January 1, 2002, the Company adopted SFAS No. 144, “Accounting
for the Impairment or Disposal of Long-Lived Assets.” SFAS No.
144 supersedes SFAS No. 121 and requires that one accounting impairment model be
used for long-lived assets to be held and used and to be disposed of by sale,
whether previously held and used or newly acquired, and broadens the
presentation of discontinued operations to include more disposal transactions.
The adoption of SFAS No. 144 had no financial impact on the results of
operations or financial position of the Company.
Estimates—The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates.
42
Foreign
Exchange Rate Swap Agreement—In
September 2002, the Company entered into a foreign exchange rate swap allowing
the Company the right to purchase up to $1.8 million at a base rate of 1.0444
Euros per $1.00. Under the agreement, the Company and the bank are to compensate
one another based on the exchange rate agreement differential at specified
measurement dates. This foreign exchange rate agreement did not qualify for
special hedge accounting treatment. Therefore the changes in fair value were
included in the determination of earnings.
This
foreign exchange rate agreement, set to expire in September 2003, was terminated
in December 2002. During the year ended December 31, 2002, the Company
recognized a loss of $105,000 related to the change in fair value and the
subsequent termination of the foreign exchange rate agreement. This loss is
included in other income, net in the accompanying consolidated statements of
operations. There was no activity in 2004 or 2003 relating to foreign exchange
rate swap agreements.
Impact
of Recently Issued Accounting Standards
In
January 2003, the FASB issued and subsequently revised in December of 2003, FIN
46, "Consolidation
of Variable Interest Entities." This
interpretation of ARB No. 51, "Consolidated
Financial Statements,"
addresses consolidation by business enterprises of variable interest entities.
Under current practice, two enterprises generally have been included in
consolidated financial statements because one enterprise controls the other
through voting interests. FIN 46 defines the concept of "variable interests" and
requires existing unconsolidated variable interest entities to be consolidated
by their primary beneficiaries if the entities do not effectively disperse the
risks among the parties involved. FIN 46 applied immediately to variable
interest entities created after January 31, 2003, and to variable interest
entities in which an enterprise obtains an interest after that date. It applied
in the first fiscal year or interim period beginning after June 15, 2003, to
variable interest entities in which an enterprise holds a variable interest that
it acquired before February 1, 2003. FIN 46(R) deferred the effective date of
FIN 46 to the first reporting period ending after December 15, 2003. If it is
reasonably possible that an enterprise will consolidate or disclose information
about a variable interest entity when this interpretation becomes effective, the
enterprise shall disclose information about those entities in all financial
statements issued after January 31, 2003. FIN 46 may be applied prospectively
with a cumulative-effect adjustment as of the date on which it is first applied
or by restating previously issued financial statements for one or more years
with a cumulative-effect adjustment as of the beginning of the first year
restated. In light of current proposed changes to FIN 46, we are continuing our
assessment to determine whether we are party to any variable interest entities.
In May
2003, the FASB issued SFAS No. 150, “Accounting
for Certain Financial Instruments with Characteristics of both Liabilities and
Equity.” SFAS No.
150 establishes standards for how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. SFAS
No. 150 requires that an issuer classify a financial instrument that is within
its scope as a liability (or an asset in some circumstances). SFAS No. 150 was
effective at the beginning of the first interim period beginning after June 15,
2003. The adoption of SFAS No. 150 did not have a material impact on our
financial position or results of operations.
In
November 2004, the FASB issued SFAS No. 151, “Inventory
Costs, an Amendment of ARB No. 43, Chapter 4.” SFAS No.
151 retains the general principle of ARB No. 43, Chapter 4, “Inventory
Pricing,” that
inventories are presumed to be stated at cost; however, it amends ARB No. 43 to
clarify that abnormal amounts of idle facilities, freight, handling costs and
spoilage should be recognized as current period expenses. Also, SFAS No. 151
requires fixed overhead costs be allocated to inventories based on normal
production capacity. The guidance in SFAS No. 151 is effective for inventory
costs incurred during fiscal years beginning after June 15, 2005. The Company
believes that implementing SFAS No. 151 will not have a material impact on its
financial position or results of operations.
In
December 2004, the FASB issued SFAS No. 123R, “Share-Based
Payment.” SFAS No.
123R requires employee stock options and rights to purchase shares under stock
participation plans to be accounted for under the fair value method, and
eliminates the ability to account for these instruments under the intrinsic
value method prescribed by APB Opinion No. 25, as allowed under the original
provisions of SFAS No. 123. SFAS No. 123R requires the use of an option pricing
model for estimating fair value, which is amortized to expense over the service
periods. The requirements of SFAS No. 123R are effective for fiscal periods
beginning after June 15, 2005. Net income in the financial statements for the
period ending December 31, 2004, would have been reduced by approximately
$1.2 million using the Black-Scholes option pricing model as applied under SFAS
123. This amount may change, as management is in the process of assessing the
various option pricing models allowed under SFAS No. 123(R).
43
Reclassification-Certain
2003 and 2002 amounts have been reclassified to conform with the 2004
presentation.
2.
ACQUISITION
On
January 16, 2002, the Company acquired SpatialMetriX Corporation (SMX) in
exchange for 500,000 shares of FARO common stock and the satisfaction by the
Company of certain obligations of SMX. In connection therewith, the Company
issued an additional 350,000 shares of FARO common stock and paid $2.0 million
in cash to fully satisfy SMX’s obligations to its two lenders. The value
attributed to the 500,000 and 350,000 shares of FARO common stock was $1,125,000
and $787,500, respectively based on the market value of the stock on January 16,
2002 represented by the $2.25 closing price of the stock on the NASDAQ stock
exchange. The Company also assumed and/or satisfied other obligations of SMX.
The transaction was recorded utilizing the purchase method of accounting in
accordance with SFAS No. 141, “Business
Combinations.”
The final
allocation of the purchase price among tangible and intangible assets and
liabilities was as follows:
Tangible
assets |
$ |
3,723,000 |
||
Intangible
assets: |
||||
Purchased
technology |
1,500,000
|
|||
Patents
and licenses |
500,000
|
|||
Goodwill |
7,243,000
|
|||
Liabilities
assumed |
(5,778,000 |
) | ||
$ |
7,188,000 |
|||
The
operating results of SMX have been included in the consolidated statements of
operations since the date of acquisition. The following unaudited pro-forma
results of operations for the year ended December 31, 2002 are presented for
informational purposes assuming the Company had owned SMX for the entire year.
These unaudited pro-forma results of operations have been prepared for
comparative purposes only and do not purport to be indicative of the results of
operations which actually would have resulted, or the results of operations
which may result in the future.
|
Year
ended |
|||
|
December
31, 2002 |
|||
Revenues |
$ |
46,374,076 |
||
Net
Loss |
(2,520,984 |
) | ||
Loss
per Share |
||||
Basic |
$ |
(0.21 |
) | |
Diluted |
$ |
(0.21 |
) | |
In 2003
the Company recorded approximately $1.1 million in other income, net in the
accompanying consolidated statements of operations as a result of receiving
approximately 100,000 shares of Company stock related to a positive arbitration
settlement between the Company and the former SMX shareholders.
44
3. SUPPLEMENTAL
CASH FLOW INFORMATION
Selected
cash payments and non-cash activities were as follows:
|
Years
ended December 31, |
| ||||||||
|
|
|
2004 |
|
|
2003 |
|
|
2002 |
|
Cash
paid for interest |
$ |
12,068 |
$ |
47,276 |
$ |
22,927 |
||||
Cash
paid for income taxes |
356,730
|
1,525,644
|
-
|
|||||||
Non-cash
investing and financing activities: |
||||||||||
Fixed
assets acquired under capital lease obligations |
316,943
|
60,953
|
42,376
|
|||||||
Issuance
of common stock in connection with the |
||||||||||
SMX
acquisition |
-
|
-
|
1,827,500
|
|||||||
Conversion
of SMX notes receivable in connection with the SMX
acquisition |
-
|
-
|
2,875,000
|
|||||||
Retirement
of fully depreciated property and equipment |
4,016,184
|
-
|
-
|
4.
ALLOWANCE FOR DOUBTFUL ACCOUNTS
The
allowance for doubtful accounts is as follows:
|
Years
ended December 31, |
|||||||||
2004 |
|
|
2003 |
|
|
2002 |
||||
Balance,
beginning of year |
$ |
254,915 |
$ |
851,852 |
$ |
339,715 |
||||
Provision |
154,394
|
140,249
|
582,463
|
|||||||
Amounts
written off, net of recoveries |
(70,569 |
) |
(737,186 |
) |
(70,326 |
) | ||||
Balance,
end of year |
$ |
338,740 |
$ |
254,915 |
$ |
851,852 |
5.
SHORT-TERM INVESTMENTS
Short-term
investments consist of the following:
|
December
31, |
| |||||
|
|
|
2004 |
|
|
2003 |
|
Corporate
bonds |
$ |
- |
$ |
432,153 |
|||
Variable
Rate Municipal Bonds |
22,485,000
|
15,605,055
|
|||||
$ |
22,485,000 |
$ |
16,037,208 |
The Underlying investments of the Company's variable
rate municipal bonds are long term tax-exempt municipal bonds. These variable
rate municipal bonds mature every seven days, at which time the interest rate
adjusts to current market conditions. As they are available for sale securities,
the Company has classified them as short-term investments on the accompanying
consolidated balance sheets.
45
6. INVENTORIES
Inventories
consist of the following:
|
December
31, |
| |||||
|
|
|
2004 |
|
|
2003 |
|
Raw
materials |
$ |
6,620,046 |
$ |
5,624,061 |
|||
Work-in-process |
427,832
|
352,104
|
|||||
Finished
goods |
1,423,592
|
1,589,759
|
|||||
Sales
Demonstration Inventory |
8,097,401
|
4,859,250
|
|||||
Reserve
for Obsolescence |
(191,101 |
) |
(154,647 |
) | |||
Inventory |
16,377,770
|
12,270,527
|
|||||
Service
Inventory |
4,159,087
|
2,501,265
|
|||||
Total |
$ |
20,536,857 |
$ |
14,771,792 |
7. GOODWILL
The
Company’s goodwill at December 31, 2004 and 2003 is related to its acquisition
of two previous businesses. The Company tests for goodwill impairment in
accordance with SFAS No. 142, “Goodwill
and Other Intangible Assets.” The
Company evaluates each reporting unit’s fair value versus its carrying value in
the fourth quarter of each year or more frequently if events or changes in
circumstances indicate that the carrying value may exceed the fair value. When
estimating the reporting unit’s fair value, the Company utilizes gross profit
for each reporting unit and a multiple based on industry averages for each
reporting unit and compares this against the carrying value. Impairments to
goodwill are charged against earnings in the period the impairment is
identified. The Company has two reporting units for which goodwill was tested on
December 31, 2004. As of December 31, 2004 and 2003, the Company did not have
any goodwill that was identified as impaired. The increase (decrease) in
goodwill of $75,250 and ($168,590) in 2004 and 2003, respectively relates
entirely to the translation of foreign currency balances.
8. INTANGIBLE
ASSETS
Intangible
assets consist of the following:
December
31, |
| ||||||
|
|
2004 |
|
2003 |
| ||
Amortizable
intangible assets: |
|||||||
Existing
product technology |
$ |
6,615,774 |
$ |
5,527,108 |
|||
Patents |
2,625,031
|
2,206,750
|
|||||
Other |
5,855,035 |
5,552,613 |
|||||
Total |
15,095,840
|
13,286,471
|
|||||
Accumulated
amortization |
(11,778,312 |
) |
(10,098,436 |
) | |||
Total
amortizable intangible assets, net |
3,317,528 |
3,188,035 |
|||||
Non-amortizable intangible assets: | |||||||
Customer
relationships |
250,000
|
250,000
|
|||||
Intangible
assets - net |
$ |
3,567,528 |
$ |
3,438,035 |
46
Amortization
expense was $886,393, $986,805 and
$1,156,668, in 2004, 2003, and 2002, respectively. The estimated amortization
expense for each of the five succeeding fiscal years is as follows:
Years
ending December 31, |
Amount
|
|||
2005 |
$ |
889,507 |
||
2006 |
651,728
|
|||
2007 |
342,750
|
|||
2008 |
312,914
|
|||
2009 |
312,914
|
|||
Thereafter |
1,057,715
|
|||
$ |
3,567,528 |
9. ACCRUED
LIABILITIES
Accrued
liabilities consist of the following:
December
31, |
| ||||||
|
|
2004 |
|
2003 |
|||
Accrued
compensation and benefits |
$ |
3,046,239 |
$ |
2,418,110 |
|||
Accrued
warranties |
564,744
|
589,622
|
|||||
Professional
and legal fees |
929,510
|
555,875
|
|||||
Other
accrued liabilities |
2,711,415
|
1,213,171
|
|||||
$ |
7,251,908 |
$ |
4,776,778 |
Activity
related to accrued warranties was as follows:
December
31, |
|||||||
|
2004 |
|
2003 |
||||
Beginning
Balance |
$ |
589,622 |
$ |
114,611 |
|||
Provision
for warranty expense |
739,771
|
1,487,961
|
|||||
Warranty
expired |
(764,649 |
) |
(1,012,950 |
) | |||
Ending
Balance |
$ |
564,744 |
$ |
589,622 |
10. LINE
OF CREDIT
The
Company has an available line of credit of $5,000,000. Terms of this line of
credit require the Company to maintain certain ratios and balances with respect
to a debt covenant agreement, including current ratio, consolidated EBITDA,
indebtedness to consolidated net worth, fixed charge coverage ratio and
consolidated tangible net worth. As of December 31, 2004 and 2003, the Company
was in compliance with the required ratios. Drawings under the line of credit
bear interest at a rate equivalent to LIBOR plus 1.75%. The line of credit
matures August 31, 2005. There were no amounts outstanding under the line of
credit at December 31, 2004 or 2003.
47
11. CAPITAL
LEASES
Required
future payments of obligations under capital leases are as
follows:
Capital |
||||
Lease |
||||
Year
ending December 31, |
Obligations |
|||
2005 |
$ |
124,322 |
||
2006 |
110,341
|
|||
2007 |
31,907
|
|||
Total
future minimum lease payments |
266,570
|
|||
Less
- Amounts representing interest |
(17,160 |
) | ||
Total
obligations |
249,410
|
|||
Less
- Current maturities |
(103,713 |
) | ||
$ |
145,697 |
Assets
under capital leases were $406,340 and $360,662 at December 31, 2004 and 2003,
respectively. Accumulated depreciation under capital leases was $177,630 and
$117,571 at December 31, 2004 and 2003, respectively.
12. RELATED
PARTY TRANSACTIONS
Related
party lease—The
Company leases its plant and office building from Xenon Research, Inc., all of
the issued and outstanding capital stock of which is owned by Simon Raab, our
Chief Executive Officer, and Diana Raab, his spouse. The term of the lease
expires on February 28, 2006, with a five-year renewal option. The base rent
during renewal periods will reflect changes in the U.S. Bureau of Labor
Statistics, Consumer Price Index for all Urban Consumers. Rent expense under
this lease was approximately
$398,000 in 2004, 2003 and 2002. The Company is evaluating the potential impact
of FIN 46(R) on the accounting for the assets subject to this
lease.
Related
party loans—In May
1998, the Company acquired CATS. On June 20, 2000 the Company and each of the
former CATS shareholders entered into an Amended and Restated Loan Agreement
pursuant to which the Company granted loans to the former CATS shareholders in
the aggregate amount of $1.1 million (The Loans). The Loans outstanding were for
a term of three years, at an interest rate of approximately 4.7%, and granted
the borrowers an option to extend the term for an additional three years. The
loans were repaid to the Company in 2003.
Related
party consulting services—The
Company engaged Cole & Partners, a mergers and acquisition and corporate
finance advisory service firm, to serve as the Company’s financial advisor in
connection with the Company’s acquisition in January 2002 of SMX. Stephen R.
Cole, one of the Company’s directors and member of the audit committee, is the
founding partner and president of Cole & Partners. The Company paid Cole
& Partners total fees of approximately $450,000 for its services, of which
the final payment of $300,000 was paid in 2002. No fees were paid to Cole &
Partners in 2004 or 2003.
48
13. OTHER
INCOME, NET
Other
income, net consists of the following:
Years
ended December 31, |
||||||||||
2004 |
|
2003 |
|
2002 |
||||||
Foreign
exchange gains |
$ |
336,734 |
$ |
489,542 |
$ |
272,000 |
||||
Litigation
settlement |
-
|
1,155,973
|
-
|
|||||||
Other |
24,985
|
314,291
|
329,336
|
|||||||
Total
other income |
$ |
361,719 |
$ |
1,959,806 |
$ |
601,336 |
14. INCOME
TAXES
Income
(loss) before income taxes consists of the following:
Years
ended December 31, |
| |||||||||
|
|
2004
|
|
2003
|
|
2002
|
||||
Domestic |
$ |
5,729,054 |
$ |
6,455,000 |
$ |
(1,349,335 |
) | |||
Foreign |
9,560,111
|
2,980,270
|
(455,496 |
) | ||||||
Income
(Loss) before income taxes |
$ |
15,289,165 |
$ |
9,435,270 |
$ |
(1,804,831 |
) |
The
components of the income tax expense (benefit) for income taxes are as follows:
Years
ended December 31, |
||||||||||
|
2004
|
2003
|
2002
|
|||||||
Current: |
||||||||||
Federal |
$ |
987,493 |
$ |
1,535,214 |
$ |
119,076 |
||||
State |
64,892
|
100,886
|
15,244
|
|||||||
Foreign |
1,316,133
|
571,561
|
-
|
|||||||
2,368,518
|
2,207,661
|
134,320
|
||||||||
Deferred: |
||||||||||
Federal |
(278,415 |
) |
(985,378 |
) |
71,708
|
|||||
State |
(18,296 |
) |
(64,753 |
) |
4,712
|
|||||
Foreign |
(1,713,516 |
) |
-
|
-
|
||||||
(2,010,227 |
) |
(1,050,131 |
) |
76,420
|
||||||
$ |
358,291 |
$ |
1,157,530 |
$ |
210,740 |
49
Income
tax expense (benefit) for the years ended December 31, 2004, 2003, and 2002
differ from the amount computed by applying the federal statutory corporate rate
to income (loss) before income taxes. The
differences are reconciled as follows:
Years
ended December 31, |
||||||||||
|
|
2004
|
|
2003
|
|
2002
|
||||
Tax
expense (benefit) at statutory rate of 35% |
$ |
5,351,208 |
$ |
3,302,348 |
$ |
(510,740 |
) | |||
State
income taxes, net of federal benefit |
147,141
|
291,871
|
(32,078 |
) | ||||||
Foreign
tax rate difference |
(1,308,822 |
) |
601,931
|
638,794
|
||||||
Research
and development credit |
(270,000 |
) |
(106,047 |
) |
(157,177 |
) | ||||
Nondeductible
items |
33,586
|
160,612
|
27,134
|
|||||||
Change
in valuation allowance |
(3,191,047 |
) |
(3,973,812 |
) |
244,807
|
|||||
Change
in foreign tax rate |
-
|
380,627
|
-
|
|||||||
Accrual
for tax uncertainties |
(403,775 |
) |
500,000
|
-
|
||||||
Total
income tax expense |
$ |
358,291 |
$ |
1,157,530 |
$ |
210,740 |
The
components of the Company’s net deferred income tax asset are as follows:
December
31, |
| ||||||
|
|
2004
|
|
2003
|
|||
Net
deferred income tax asset - Current |
|||||||
Product
design costs |
$ |
(175,117 |
) |
$ |
(248,126 |
) | |
Tax
credits |
-
|
675,132
|
|||||
Intercompany
profit in inventory |
993,596
|
-
|
|||||
Warranty
costs |
140,585
|
-
|
|||||
Other |
29,051
|
137,835
|
|||||
Deferred
income tax asset - Current |
988,115
|
564,841
|
|||||
Valuation
Allowance |
(243,732 |
) |
-
|
||||
Net
deferred income tax asset - Current |
$ |
744,383 |
$ |
564,841 |
|||
Net
deferred income tax asset - Non-current |
|||||||
Depreciation |
$ |
852,632 |
$ |
812,431 |
|||
Goodwill
amortization |
(649,512 |
) |
(323,490 |
) | |||
Employee
stock options |
188,444
|
227,545
|
|||||
Unearned
service revenue |
617,313
|
427,260
|
|||||
Tax
credits |
1,018,854
|
-
|
|||||
Loss
carryforwards |
3,649,162
|
4,838,235
|
|||||
Deferred
income tax asset - Non-current |
5,676,893
|
5,981,981
|
|||||
Valuation
Allowance |
(1,403,456 |
) |
(4,838,235 |
) | |||
Net
deferred income tax asset - Non-current |
$ |
4,273,437 |
$ |
1,143,746 |
At
December 31, 2004 and 2003, the Company’s domestic entities had deferred income
tax assets in the amount of $3,306,378 and $1,708,587, respectively. The Company
has determined that these amounts are fully realizable and have not established
any valuation allowance based on the assessment that they are
more-likely-than-not to be utilized.
50
At
December 31, 2004 and 2003, the Company’s foreign subsidiaries had deferred
income tax assets relating to net operating loss carry forwards, which do not
expire, of $3,358,630 and $4,838,235, respectively. For financial reporting
purposes, a valuation allowance of $1,647,188 and $4,838,235, respectively has
been recognized to offset the deferred tax assets relating to net operating
losses. The Company has determined that the amount of deferred tax assets
relating to the net operating loss carryforwards of foreign subsidiaries was
understated at December 31, 2003. The understatement was due to the tax
treatment of intercompany debt waivers that were determined in 2004 to be exempt
from tax, and resulted in an adjustment to beginning balances of approximately
$3.7 million for deferred tax assets relating to the net operating loss
carryforwards and has been reflected in the above schedule of deferred income
tax assets as of December 31, 2003. As these net operating loss carryforwards
would have been fully reserved at December 31, 2003 by a valuation allowance,
there is no income statement or balance sheet impact to be recognized for 2003.
The
Company continues to maintain a valuation allowance on net operating losses in
jurisdictions for which it does not have a history of earnings over the last
three years and where the Company believes that the deferred tax assets are not
more-likely-than-not to be realized. The Company reduced the overall valuation
allowance in 2004 and 2003 on its deferred tax assets in the amount of
$3,191,047 and $3,973,812, respectively. The reduction in the valuation
allowance for 2004 relates to the net use of deferred tax assets in foreign
jurisdictions and to the release of $1,713,347 in valuation allowance in a
foreign jurisdiction in the fourth quarter. The release of the valuation
allowance was based on one of its foreign units having demonstrated a history of
earnings over the past three years, and with management’s assessment that the
unit will be more-likely-than-not to utilize their deferred tax assets.
Management calculated the amount to release from the valuation allowance using
projections of future taxable earnings over the next two years.
At
December 31, 2004 and 2003, the Company had $1,018,854 and $675,132 in tax
credits, respectively. These credits are related to the Company’s research and
development activities and expire in 17 to 20 years. The Company fully expects
to realize these credits before expiration.
The
Company operates in a number of different countries around the world. In 2003
the Company began to manufacture its products in Switzerland, where it has
received a permanent income tax rate commitment from the Swiss government as an
incentive to establish a manufacturing plant there. The Company does not provide
deferred tax assets on temporary differences scheduled to reverse after the
commitment period because all of its earnings are included in the current tax
provision. Approximately 60% of all finished goods shipments come from the Swiss
plant, with the balance coming from the Company’s manufacturing facilities
located in the United States.
We have
not recognized any U.S. tax expense on undistributed international earnings
since we intend to reinvest the earnings outside the U.S. for the foreseeable
future. Our undistributed international earnings were approximately $5.4 million
and $2.8 million at December 31, 2004, and 2003, respectively.
Significant
judgment is required in determining our worldwide provision for income taxes. In
the ordinary course of a global business, there are many transactions for which
the ultimate tax outcome is uncertain. The Company reviews its tax contingencies
on a regular basis and makes appropriate accruals as necessary.
15.
SHARE ISSUANCE
On
November 12, 2003, the Company sold 1,158,000 shares of its common stock, and
two of the Company’s founders sold 772,000 shares of the Company’s common stock
to institutional investors in a private placement that was not registered under
the Securities Act of 1933. The shares were sold for $21.50 per share, resulting
in total proceeds before placement agent fees and other offering expenses of
$24.9 million and $16.6 million to the Company and the co-founders,
respectively. The purchasers of the shares sold in the transaction were 31
institutional investors. Robert W. Baird & Co. served as the placement agent
for the transaction, and received a fee equal to $2,489,700, or 6% of the
aggregate sales proceeds. The Company also reimbursed Robert W. Baird & Co.
for $50,000 in expenses incurred in connection with the transaction.
51
16.
COMMITMENTS AND CONTINGENCIES
Leases—The
following is a schedule of future minimum lease payments required under
non-cancelable operating leases with initial terms in excess of one year,
including leases with related parties (see Note 12), in effect at
December 31, 2004:
Years
Ending December 31, |
Amount
|
|||
2005 |
$ |
1,548,116 |
||
2006 |
1,125,632
|
|||
2007 |
408,460
|
|||
2008 |
232,437
|
|||
2009 |
221,720
|
|||
Thereafter |
-
|
|||
Total
future minimum lease payments |
$ |
3,536,365 |
Rent
expense for 2004, 2003, and 2002, was approximately $1,651,000, $1,148,000 and
$1,004,000, respectively.
Litigation—The
Company is not involved in any pending legal proceedings other than routine
litigation arising in the normal course of business. The Company does not
believe the results of such litigation, even if the outcome were unfavorable to
the Company, would have a material adverse effect on the Company’s business,
financial condition or results of operations.
17.
STOCK COMPENSATION PLANS
The
Company has four stock option plans that provide for the granting of stock
options to key employees and non-employee members of the Board of Directors. The
1993 Stock Option Plan (1993 Plan) and the 1997 Employee Stock Option Plan (1997
Plan) provide for granting incentive stock options and nonqualified stock
options to officers and key employees of the Company. The 1997 Non-employee
Director Plan provides for granting nonqualified stock options and formula
options to non-employee directors. The 2004 Equity Incentive Plan (2004 Plan)
provides for granting options or stock appreciation rights to employees and
non-employee directors.
The
Company is authorized to grant options for up to 703,100 shares of common stock
under the 1993 Plan, of which 5,032 options are currently outstanding at an
exercise price of $3.60. These options primarily vest over 3 and 4-year periods.
The Company is also authorized to grant options for up to 1,400,000 shares of
common stock under the 1997 Plan, of which 526,836 options are currently
outstanding at exercise prices between $1.50 and $27.40. These options vest over
a 3-year period. The Company is also authorized to grant up to 250,000 shares of
common stock under the 1997 Non-employee Director Plan of which 84,000 options
are currently outstanding at exercise prices between $1.61 and $21.56. Each
non-employee director is granted 3,000 options upon election to the Board of
Directors and then annually upon attending the annual meeting of shareholders
(formula options). Formula options granted to directors are generally granted
upon the same terms and conditions as options granted to officers and employees.
These options vest over a 3-year period. The Company is also authorized to grant
options for up to 1,750,000 shares of common stock under the 2004 Plan, of which
599,372 options are currently outstanding at exercise prices between $19.34 to
$24.35. These options vest over a 3-year period.
In
addition to the four stock option plans, the Company has the 1997 Non-Employee
Directors Fee Plan (1997 Fee Plan) under which the Company is authorized to
issue up to 250,000 shares of Common Stock and permits non-employee directors to
elect to receive directors’ fees in the form of common stock rather than cash.
Common stock issued in lieu of cash directors’ fees is issued at the end of the
quarter in which the fees are earned, with the number of shares being based on
the fair market value of the common stock for the five trading days immediately
preceding the last business day of the quarter. The 1997 Fee Plan also permits
non-employee directors to irrevocably elect to defer receipt of all or any
portion of the shares of common stock which would otherwise be payable. As of
December 31, 2004 and 2003 there were 35,941 shares accrued but not yet issued
in connection with director’s elections.
52
In the
fourth quarter of 2001, the Company cancelled approximately 548,000 “out of the
money” options, including approximately 440,000 options issued under the 1997
Plan and approximately 108,000 options issued under the 1997 Non-employee
Director Plan. As a result, 62,806 options granted in 2001, under the 1997 Plan
and to holders of some of the options cancelled, were subjected to variable
accounting treatment. Under FIN 44, stock options issued within six months of a
cancellation must be accounted for as variable under certain circumstances.
Variable accounting requires companies to re-measure compensation costs for the
variable options based on the Company’s share price until the options are
exercised, cancelled or forfeited without replacement. Compensation is dependent
on fluctuations in the quoted market prices for the Company’s common stock. Such
compensation costs will be recognized over a three-year vesting schedule until
the options are fully vested, exercised, cancelled or forfeited, after which
time the compensation will be recognized immediately at each reporting period.
Compensation
costs charged to operations associated with the Company’s stock option plans
were $277,028, $718,524, and
$9,526 in
2004, 2003, and 2002, respectively. The changes in stock option associated
compensation cost were due
to the market price fluctuation in the Company’s common stock.
A summary
of stock option activity and weighted average exercise prices follows:
Years
Ended December 31, |
| ||||||||||||||||||
|
|
2004 |
|
2003 |
|
2002 |
|||||||||||||
Options |
|
Weighted-Average
Exercise Price |
|
Options |
|
Weighted-Average
Exercise Price |
|
Options |
|
Weighted-Average
Exercise Price |
|||||||||
Outstanding
at beginning of year |
978,952
|
$ |
2.42 |
1,554,513
|
$ |
2.41 |
949,498
|
$ |
4.19 |
||||||||||
Granted |
750,730
|
20.86
|
22,500
|
5.39
|
958,945
|
2.20
|
|||||||||||||
Forfeited |
(28,930 |
) |
8.06
|
(69,222 |
) |
2.13
|
(352,930 |
) |
8.32
|
||||||||||
Exercised |
(485,512 |
) |
2.41
|
(528,839 |
) |
2.46
|
(1,000 |
) |
0.36
|
||||||||||
Outstanding
at end of year |
1,215,240
|
$ |
13.69 |
978,952
|
$ |
2.42 |
1,554,513
|
$ |
2.41 |
||||||||||
Outstanding
exercisable at year-end |
339,465
|
$ |
6.40 |
501,631
|
$ |
2.61 |
701,042
|
$ |
2.77 |
||||||||||
Weighted-average
fair value of options |
|||||||||||||||||||
granted
during the year |
$ |
13.67 |
$ |
3.35 |
$ |
1.25 |
A summary
of stock options outstanding and exercisable as of December 31, 2004 follows:
|
Weighted-Average |
Average |
|
Average |
||||||||||||
Exercise |
|
Options |
Remaining |
Exercise |
Options |
Exercise |
||||||||||
Price |
|
Outstanding |
|
Contractual
Life (years) |
|
Price |
|
Exercisable |
|
Price |
||||||
$1.50 |
71,651
|
6.84
|
$ |
1.50 |
71,651
|
$ |
1.50 |
|||||||||
$1.51-$3.00 |
362,545
|
7.20
|
2.23
|
181,024
|
2.29
|
|||||||||||
$3.01-$10.00 |
49,533
|
6.75
|
4.67
|
27,864
|
4.13
|
|||||||||||
$10.01-$20.00 |
417,027
|
9.56
|
19.24
|
4,577
|
10.34
|
|||||||||||
Over
$20.00 |
314,484
|
9.38
|
23.74
|
54,349
|
27.40
|
|||||||||||
1,215,240
|
8.53
|
$ |
13.69 |
339,465
|
$ |
6.40 |
Remaining
non-exercisable options as of December 31, 2004 become exercisable as follows:
Years
ending December 31, |
Amount |
|||
2005 |
452,147
|
|||
2006 |
218,788
|
|||
2007 |
204,840
|
|||
875,775
|
53
18.
EARNINGS (LOSS) PER SHARE
A
reconciliation of the number of common shares used in the calculation of basic
and diluted earnings per share (EPS) and loss per share (LPS) is presented
below:
Years
ended December 31, |
|||||||||||||||||||
2004 |
|
2003 |
|
2002 |
| ||||||||||||||
|
|
PER-SHARE |
|
PER-SHARE |
|
PER-SHARE |
|||||||||||||
|
|
SHARES |
|
AMOUNT |
|
SHARES
|
|
AMOUNT |
|
SHARES
|
|
AMOUNT |
|||||||
Basic
EPS (LPS) |
13,833,590
|
$ |
1.08 |
12,181,221
|
$ |
0.68 |
11,853,732
|
$ |
(0.17 |
) | |||||||||
Effect
of Dilutive Securities: |
|||||||||||||||||||
Stock
Options |
189,569
|
(0.02 |
) |
664,771
|
(0.04 |
) |
-
|
-
|
|||||||||||
Diluted
EPS (LPS) |
14,023,159
|
$ |
1.06 |
12,845,992
|
$ |
0.64 |
11,853,732
|
$ |
(0.17 |
) |
The
effect of 92,532 dilutive securities was not included in the computations for
2002 as they were antidilutive.
19.
EMPLOYEE RETIREMENT BENEFIT PLAN
The
Company maintains a 401(k) defined contribution retirement plan for its U.S.
employees, which provides benefits for all employees meeting certain age and
service requirements. The Company may make a discretionary contribution each
plan year, as determined by its Board of Directors. Discretionary contributions
or employer matches can be made to the participant’s account but cannot exceed
6% of compensation. Costs charged to operations in connection with the Plan
during 2004, 2003, and 2002 aggregated $172,403, $113,316, and $102,900,
respectively.
20.
GEOGRAPHIC DATA
The
Company develops, manufactures, markets and supports CAD-based quality assurance
products integrated with CAD-based inspection and statistical process control
software. This one line of business represents approximately 99% of consolidated
sales and is the Company’s only segment. The Company operates through sales
teams established by geographic area. Each team is equipped to deliver the
entire line of Company products to customers within its geographic area.
The
following table presents information about the Company by geographic area:
As
of and for the year ended December 31, |
| ||||||||||||||||||
|
|
2004 |
|
2003 |
|
2002 |
| ||||||||||||
|
|
Sales |
|
Long-lived
Assets |
|
Sales |
|
Long-lived
Assets |
|
Sales |
|
Long-lived
Assets |
|||||||
Americas
Region |
$ |
41,680,193 |
$ |
2,314,907 |
$ |
37,862,618 |
$ |
1,467,054 |
$ |
22,471,470 |
$ |
1,304,701 |
|||||||
Europe/Africa
Region |
43,110,719 |
1,238,891 |
27,700,696 |
1,105,920 |
18,490,654 |
608,564 |
|||||||||||||
Asia
Pacific Region |
12,228,963 |
461,028 |
6,222,666 |
180,383 |
5,284,248 |
104,594 |
|||||||||||||
$ |
97,019,875 |
$ |
4,014,826 |
$ |
71,785,980 |
$ |
2,753,357 |
$ |
46,246,372 |
$ |
2,017,859 |
The
geographical sales information presented above represents sales to customers
located in each respective region whereas the long-lived assets information
represents assets held in the respective regions.
54
21.
QUARTERLY RESULTS OF OPERATIONS (UNAUDITED)
April
3, |
July
3, |
October
2 |
December
31, |
||||||||||
Quarters
Ended |
|
2004 |
|
2004 |
|
2004 |
|
2004 |
| ||||
Sales |
$ |
21,025,192 |
$ |
24,076,847 |
$ |
23,375,534 |
$ |
28,542,302 |
|||||
Gross
profit |
13,463,835
|
15,227,932
|
14,757,266
|
16,547,138
|
|||||||||
Net
income |
2,848,408
|
4,102,591
|
3,065,411
|
4,914,464
|
|||||||||
Net
income per share: |
|||||||||||||
Basic |
$ |
0.21 |
$ |
0.30 |
$ |
0.22 |
$ |
0.35 |
|||||
Diluted |
$ |
0.20 |
$ |
0.29 |
$ |
0.22 |
$ |
0.34 |
|
|
March
29, |
June
28, |
September
27, |
December
31, |
||||||||
Quarters
Ended |
|
2003 |
|
2003 |
|
2003 |
|
2003 |
| ||||
Sales |
$ |
13,404,265 |
$ |
16,243,469 |
$ |
19,183,956 |
$ |
22,954,290 |
|||||
Gross
profit |
7,504,685
|
10,060,436
|
11,030,876
|
13,669,735
|
|||||||||
Net
income |
489,364
|
1,558,049
|
3,333,888
|
2,896,439
|
|||||||||
Net
income per share: |
|||||||||||||
Basic |
$ |
0.04 |
$ |
0.13 |
$ |
0.28 |
$ |
0.23 |
|||||
Diluted |
$ |
0.04 |
$ |
0.12 |
$ |
0.26 |
$ |
0.22 |
22.
SUBSEQUENT EVENT
On
January 10, 2005 the Company filed a Registration Statement on Form S-3 with the
Securities and Exchange Commission for Debt Securities, common stock with par
value of $0.001 per share, Warrants or Units consisting of two or more of the
foregoing in the total amount of $125,000,000.
55
Item
9.
Changes in and Disagreements with Accountants on Accounting and Financial
Disclosure.
Effective
as of November 16, 2004, our Audit Committee dismissed Ernst & Young LLP as
our independent auditing firm. During Ernst & Young’s retention as our
independent auditing firm, there were no disagreements with Ernst & Young on
any matter of accounting principle or practice, financial statement disclosure,
or auditing scope or procedure which, if not resolved to Ernst & Young’s
satisfaction, would have caused them to make reference to the subject matter of
the disagreement in connection with their reports. Similarly, none of the
reportable events described under Item 304(a)(1)(v) of Regulation S-K have
occurred during the time that Ernst & Young had been engaged as our
independent auditing firm.
None of
Ernst & Young’s audit reports on our consolidated financial statements
contained any adverse opinion or disclaimer of opinion, nor were they qualified
or modified as to uncertainty, audit scope or accounting principles.
Effective
as of November 15, 2004, our Audit Committee retained Grant Thornton LLP as our
independent auditing firm for our fiscal 2004. During the years ended December
31, 2002 and 2003 and through November 15, 2004, we did not, nor did anyone
acting on our behalf, consult with Grant Thornton regarding the application of
accounting principles to a specified transaction, either completed or proposed,
the type of audit opinion that might be rendered on our financial statements, or
any reportable events described under Items 304(a)(2)(ii) of Regulation
S-K.
Item
9A.
Controls and Procedures.
Evaluation
of Disclosure Controls and Procedures
As of
December 31, 2004, management carried out an evaluation, under the supervision
and with the participation of its Chief Executive Officer and Chief Financial
Officer, of the effectiveness of the design and operation of its disclosure
controls and procedures as such term is defined under Securities Exchange Act of
1934, as amended (the “Exchange Act”) Rule 13a-15(e). Based on this evaluation,
management has concluded that as of December 31, 2004, such disclosure controls
and procedures were effective to provide reasonable assurance that the Company
records, processes, summarizes and reports the information the Company must
disclose in reports that the Company files or submits under the Exchange Act
within the time periods specified in the SEC’s rules and forms.
Management’s
Report on Internal Control Over Financial Reporting
Our Chief
Executive Officer and Chief Financial Officer, together with other members of
management of FARO Technologies Inc., are responsible for establishing and
maintaining adequate internal control over financial reporting.
Internal
control over financial reporting is the process designed under our supervision,
and effected by our Board of Directors, management and other personnel, to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of our financial statements for external purposes in
accordance with accounting principles generally accepted in the United States of
America.
There are
inherent limitations in the effectiveness of internal control over financial
reporting, including the possibility that misstatements may not be prevented or
detected. Accordingly, even effective internal controls over financial reporting
can provide only reasonable assurance with respect to financial statement
preparation. Furthermore, the effectiveness of internal controls can change with
circumstances.
Management
has evaluated the effectiveness of internal control over financial reporting as
of December 31, 2004, in relation to criteria described in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations
Commission of the Treadway Commission (COSO). Based on that assessment,
management concluded that, as of December 31, 2004, our internal control over
financial reporting is effective based on the criteria established in Internal
Control-Integrated Framework.
56
Grant
Thornton LLP, our independent registered public accounting firm, has issued
their report on management's assessment of internal control over financial
reporting, which appears below.
Changes
in Internal Control Over Financial Reporting
There
were no changes in the Company’s internal control over financial reporting
during the quarter ended December 31, 2004 that have materially affected, or are
reasonably likely to materially affect, the Company’s internal control over
financial reporting.
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors and Shareholders of FARO Technologies, Inc.:
We have
audited management's assessment, included in the accompanying Management’s
Report on Internal Controls and Procedures, that FARO Technologies, Inc. (a
Florida Corporation) maintained effective internal control over financial
reporting as of December 31, 2004, based on criteria established in Internal
Control—Integrated Framework issued by the Committee of Sponsoring Organizations
of the Treadway Commission (COSO). FARO Technologies, Inc.'s management is
responsible for maintaining effective internal control over financial reporting
and for its assessment of the effectiveness of internal control over financial
reporting. Our responsibility is to express an opinion on management's
assessment and an opinion on the effectiveness of the company's internal control
over financial reporting based on our audit.
We
conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether effective
internal control over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of internal control over
financial reporting, evaluating management's assessment, testing and evaluating
the design and operating effectiveness of internal control, and performing such
other procedures as we considered necessary in the circumstances. We believe
that our audit provides a reasonable basis for our opinions.
A
company's internal control over financial reporting is a process designed to
provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles. A company's internal control over
financial reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of
the company; and (3) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company's
assets that could have a material effect on the financial
statements.
Because
of its inherent limitations, internal control over financial reporting may not
prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance
with the policies or procedures may deteriorate.
57
In our
opinion, management's assessment that Faro Technologies, Inc. maintained
effective internal control over financial reporting as of December 31, 2004, is
fairly stated, in all material respects, based on criteria established in
Internal Control—Integrated Framework issued by COSO. Also in our opinion, Faro
Technologies, Inc. maintained, in all material respects, effective internal
control over financial reporting as of December 31, 2004, based on criteria
established in Internal Control—Integrated Framework issued by COSO.
We have
also audited, in accordance with the standards of the Public Company Accounting
Oversight Board (United States), the consolidated balance sheet of FARO
Technologies, Inc. and subsidiaries as of December 31, 2004, and the related
consolidated statements of operations, shareholders’ equity and cash flows for
the year then ended and our report dated March 14, 2005 expressed an unqualified
opinion on those financial statements.
/s/ GRANT THORNTON LLP |
Orlando,
Florida
March 14,
2005
58
PART
III
Certain
information required by Part III is omitted from this Report in that the
Registrant will file a definitive proxy statement pursuant to Regulation 14A
(the Proxy Statement) not later than 120 days after the end of the fiscal year
covered by this Report and certain information included therein is incorporated
herein by reference. Only those sections of the Proxy Statement that
specifically address the Items set forth herein are incorporated by reference.
Such incorporation does not include the Compensation Committee Report or the
Performance Graph included in the Proxy Statement.
Item
10.
Directors and Executive Officers of the Registrant.
The
information to be set forth under the captions “Election of Directors” and
“Section 16 (a) Beneficial Ownership Reporting Compliance” in the Proxy
Statement is incorporated herein by reference.
The
information concerning the Company’s executive officers required by this Item is
incorporated by reference herein from the section of this Report in Part I, Item
1, entitled “Management of the Registrant.”
Item
11.
Executive Compensation.
The
information to be set forth under the caption “Executive Compensation” in the
Proxy Statement is incorporated herein by reference; provided, however that the
Company specifically excludes from such incorporation by reference any
information set forth under the caption “Compensation Committee Report on
Executive Compensation.”
Item
12.
Security Ownership of Certain Beneficial Owners and
Management.
Security
ownership of certain beneficial owners and management to be set forth under the
caption “Beneficial Owners and Management” and “Equity Compensation Plan
Information” in the Proxy Statement is incorporated herein by reference.
Item
13.
Certain Relationships and Related Transactions.
The
information to be set forth under the caption “Certain Relationships and Related
Transactions” in the Proxy Statement is incorporated herein by
reference.
Item
14.
Principal Accountant Fees and Services.
The
information required by this Item is incorporated herein by reference from
information included under the caption entitled “Our Independent Auditors” set
forth in our Proxy Statement.
59
Schedule
II - Valuation and Qualifying Accounts
Valuation
and Qualifying Accounts were as follows for the three years ended December 31,
2004:
Description |
Balance
at beginning of period |
|
Additions
charged to costs and expenses or revenues |
|
Deductions
for purposes for which accounts were set up |
|
Balance
at end of period |
||||||
Year
Ended December 31, 2004 |
|||||||||||||
Deducted
from assets which apply |
|||||||||||||
Uncollectible
accounts |
254,915
|
154,394
|
70,569
|
338,740
|
|||||||||
Reserve
for Inventory Obsolescence |
154,647
|
895,694
|
859,240
|
191,101
|
|||||||||
Total |
409,562
|
1,050,088
|
929,809
|
529,841
|
|||||||||
Year
Ended December 31, 2003 |
|||||||||||||
Deducted
from assets which apply |
|||||||||||||
Uncollectible
accounts |
851,852
|
140,249
|
737,186
|
254,915
|
|||||||||
Reserve
for Inventory Obsolescence |
89,969
|
904,513
|
839,835
|
154,647
|
|||||||||
Total |
941,821
|
1,044,762
|
1,577,021
|
409,562
|
|||||||||
Year
Ended December 31, 2002 |
|||||||||||||
Deducted
from assets which apply |
|||||||||||||
Uncollectible
accounts |
339,715
|
582,463
|
70,326
|
851,852
|
|||||||||
Reserve
for Inventory Obsolescence |
297,508
|
663,269
|
870,808
|
89,969
|
|||||||||
Total |
637,223
|
1,245,732
|
941,134
|
941,821
|
60
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors and Shareholders of FARO Technologies, Inc.:
We have
audited in accordance with the standards of the Public Company Accounting
Oversight Board (United States) the consolidated financial statements of FARO
Technologies, Inc. and subsidiaries referred to in our report dated March 14,
2005, which is included in the annual report to shareholders. Our audit was
conducted for the purpose of forming an opinion on the basic financial
statements taken as a whole. The Schedule II is presented for purposes of
additional analysis and is not a required part of the basic financial
statements. This schedule has been subjected to the auditing procedures applied
in the audit of the basic financial statements and, in our opinion, is fairly
stated in all material respects in relation to the basic financial statements
taken as a whole.
/s/ GRANT THORNTON LLP |
Orlando,
Florida
March 14,
2005
61
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors and Shareholders of FARO Technologies, Inc.:
We have
audited the consolidated financial statements of FARO Technologies, Inc. as of
December 31, 2003, and for each of the two years in the period ended December
31, 2003, and have issued our report thereon dated February 20, 2004 (included
elsewhere in this annual report). Our audit also included the information shown
in Schedule II of this annual report. This schedule is the responsibility of the
Company's management. Our responsibility is to express an opinion based on our
audit.
In our
opinion, the financial statement schedule referred to above, when considered in
relation to the basic financial statements taken as a whole, present fairly in
all material respects the information set forth therein.
/s/ ERNST & YOUNG LLP |
Orlando,
Florida
February
20, 2004
62
PART
IV
Item
15.
Exhibits, Financial Statement Schedules, and Reports on Form
8-K.
(a)
Documents Filed as Part of this Report. The
following documents are filed as part of this Report:
(1)
Financial Statements. Included
in Part II, Item 8 is an index to the Consolidated Financial Statements of FARO
Technologies, Inc. and Report of Grant Thornton LLP, Independent Certified
Public Accountants, filed as part of this Form 10-K.
(2)
Financial Statement Schedules. Schedules
not listed in the index to the Consolidated Financial Statements included in
Part II, Item 8, have been omitted because they are not applicable or are not
required or the information required to be set forth therein is included in the
Consolidated Financial Statements or Notes thereto.
(3)
Exhibits.
Exhibit No. |
|
Description |
3.1 |
|
Articles
of Incorporation, as amended (Filed
as Exhibit 3.1 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
3.2 |
|
Bylaws,
as amended (Filed
as Exhibit 3.2 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
4.1 |
|
Specimen
Stock Certificate (Filed
as Exhibit 4.1 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
10.1 |
|
1993
Stock Option Plan, as amended (Filed
as Exhibit 10.1 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
10.2 |
|
1997
Employee Stock Option Plan (Filed
as Exhibit 10.2 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
10.3 |
|
1997
Non-Employee Director Stock Option Plan (Filed
as Exhibit 10.3 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
63
Exhibit No. |
|
Description |
10.4 |
|
Business
Lease, dated March 1, 1991, between the Registrant (as successor-by-merger
to FARO Medical Technologies (U.S.), Inc.) and Xenon Research, Inc.
(Filed
as Exhibit 10.7 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
10.5 |
|
Nonexclusive
Unique Application Reseller Agreement, dated September 9, 1996, between
the Registrant and Autodesk, Inc. (Filed
as Exhibit 10.9 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
10.6 |
|
Form
of Patent and Confidentiality Agreement between the Registrant and each of
its employees (Filed
as Exhibit 10.10 to Registrant’s Registration Statement on Form S-1, No.
333-32983, and incorporated herein by reference) |
10.7 |
|
Nonexclusive
Unique Application Reseller Agreement, dated as of March 1, 1998, between
the Registrant and Autodesk, Inc. (Filed
as Exhibit 10.11 to Registrant’s Form 10-K for calendar year 1997, No.
0-23081, and incorporated herein by reference) |
10.8 |
|
First
Amendment to Business Lease, dated as of January 20, 1998, between the
Registrant (as successor by merger to FARO Medical Technologies (US),
Inc.) and Xenon Research, Inc., (Filed
as Exhibit 10.12 to Registrant’s Form 10-K for calendar year 1997, No.
0-23081 and incorporated herein by reference) |
10.9 |
|
Agreement
and Plan of Merger dated September 14, 2001, as amended, between the
Registrant and SpatialMetriX Corporation (Filed
as Exhibit 2.1 to Registrant’s Current report on Form 8-K dated January
16, 2002 and incorporated herein by reference) |
10.10 |
Securities
Purchase Agreement, dated November 11, 2003, by and among the Company,
Xenon Research, Inc., a Florida corporation, and Gregory A. Fraser, and
the investors named on the signature pages thereto.
(Filed as Exhibit 10.1 to Registrant’s Current report on Form 8-K dated
November
11, 2003and
incorporated herein by reference) | |
10.11 |
Loan
Agreement, dated as of September 17, 2003, by and between FARO
Technologies, Inc. and SunTrust Bank. (Filed
as Exhibit 10.2 to Registrant’s Current report on Form 8-K dated
November
11, 2003and
incorporated herein by reference) | |
21.1 |
|
List
of Subsidiaries (Filed
herewith) |
23.1 |
|
Consent
of Grant Thornton LLP (Filed
herewith) |
23.2 |
|
Consent
of Ernst & Young LLP (Filed
herewith) |
64
Exhibit No. |
|
Description |
24.1 |
|
Power
of Attorney relating to subsequent amendments (included on the signature
page(s) of this report). |
31-A |
Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31-B |
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32-A |
Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32-B |
Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
99.1 |
Properties (Filed Herewith) |
(b)
Reports on Form 8-K
On
November 18, 2004 the Company filed a report on Form 8-K in connection with a
change in the Company’s certifying accountant.
On
January 8, 2005 the Company filed a report on Form 8-K in connection with a
press release announcing our sales and new order results for the quarter and
year ended December 31, 2004.
On March
10, 2005 the Company filed a report on Form 8-K in connection with a press
release announcing our earnings for the quarter and year ended December 31,
2004.
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized
FARO TECHNOLOGIES, INC. | ||
|
|
|
Date: March 16, 2005 | By: | /s/ Gregory A. Fraser |
Gregory A. Fraser | ||
Executive
Vice President, Secretary and Treasurer
(Duly
Authorized Officer and Principal Financial
Officer) |
Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated. Each person whose signature appears below
constitutes and appoints SIMON RAAB, and GREGORY A. FRASER, and each of them
individually, his true and lawful attorney-in-fact and agent, with full power of
substitution and revocation, for him and in his name, place and stead, in any
and all capacities, to sign any and all amendments to this Report and to file
the same, with all exhibits thereto, and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said
attorneys-in-fact and agents, and each of them, full power and authority to do
and perform each and every act and thing requisite and necessary to be done in
connection therewith, as fully to all intents and purposes as he might or could
do in person, hereby ratifying and confirming all that said attorneys-in-fact
and agents, or either of them, may lawfully do or cause to be done by virtue
hereof.
65
Signature |
Title |
Date | ||
/s/
Simon Raab |
Chairman
of the Board, Chief Executive Officer |
March
16, 2005 | ||
Simon Raab |
(Principal Executive Officer), and Director | |||
/s/
Gregory A. Fraser |
Executive
Vice President, Secretary, Treasurer, and Director |
March
16, 2005 | ||
Gregory A. Fraser |
(Principal Financial Officer and Principal Accounting Officer), | |||
/s/
John Caldwell |
Director |
March
16, 2005 | ||
John Caldwell |
||||
/s/
Hubert d’Amours |
Director |
March
16, 2005 | ||
Hubert d'Amours |
||||
/s/
Stephen R. Cole |
Director |
March
16, 2005 | ||
Stephen R. Cole |
||||
/s/
Norman H. Schipper |
Director |
March
16, 2005 | ||
Norman H. Schipper |
||||
/s/
Andre Julien |
Director |
March
16, 2005 | ||
Andre Julien |
66